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In the 1950s, psychedelic drugs were the subject of extensive psychiatric 
research in the United States. By 1960, they had been found to be non-addictive, to have 
remarkable safety profiles, and to potentially be able to treat a range of psychological 
conditions. However, in 1968, the possession of psychedelics was criminalized by the 
US federal government. Consequently, medical research has been stifled, and today the 
possession and distribution of psychedelics are punished more severely than for more 
dangerous recreational drugs such as methamphetamine. Most scholars argue that 
psychedelics were criminalized due to a “moral panic” in the late 1960s. However, this 
theory overlooks several important aspects of the political process that led to 
psychedelic criminalization. This essay takes an alternative stance. First, early 20th 
century temperance advocates instilled an anti-drug moral framework into the American 
cultural consciousness. Then, in the early 1960s, safety concerns and professional biases 
led most mainstream psychiatrists to reject the therapeutic use of psychedelics. These 
factors interacted to cause both a moral panic and severe criminalization, but the moral 
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For thousands of years, multiple cultures have used psychedelic drugs for their 
medicinal properties and ability to induce mystical experiences (Siff 2015, 68). But 
today, these substances have been heavily criminalized across the developed world. In 
the United States, for example, possession or distribution of psychedelic drugs carries 
more severe penalties than even such notoriously dangerous and addictive substances as 
cocaine, methamphetamine, or morphine (DEA n.d. “Controlled Substance”).  
This has not always been the case. In the 1950s, psychedelics were not seen as 
“hard drugs,” but were touted by the American media as a revolutionary psychiatric 
medicine (Siff 2015, 61). Even in the early 1960s, as recreational use of LSD and other 
psychedelics became widespread in the US, most Americans were not highly concerned 
about recreational drug use (143). But between the 1965 and 1971, public opinion 
shifted radically. Psychedelics were soon after banned for medical as well as 
recreational purposes, first nationally in the US, and then globally via the United 
Nations Convention on Psychotropic Drugs. 
This rapid policy shift is even more intriguing because of its clear disconnect 
with scientific fact. Most psychedelics are currently classified as Schedule I by the US 
Drug Enforcement Agency (DEA), a category reserved for drugs with “no currently 
accepted medical use in the US, a lack of accepted safety for use under medical 
supervision, and a high potential for abuse” (n.d. “Controlled Substance Schedules”). 
The latter two assertions are objectively false; psychedelics are remarkably non-toxic 
and non-addictive, as has been shown in dozens of clinical studies over the past 70 




Nichols and Grob 2018). Contrary to popular belief, the psychological risks of 
psychedelic use are also negligible—very large-n studies have demonstrated no 
increased risk of mental health problems in psychedelic users (Johansen and Krebs 
2015). Additionally, while the medical use of psychedelics is not currently legal in the 
US, studies dating back to the 1950s have demonstrated the drugs’ immense potential in 
treating a range of psychiatric disorders (Liechti 2017; Winkelman 2014; Anderson et 
al. 2020; Das et al. 2016; Gasser 2014). For example, multiple recent trials have found 
that psilocybin (the active component in psychedelic mushrooms) produced significant 
clinical improvements in anxiety, depression, obsessive compulsive disorder, and 
alcohol dependence (Carhart-Harris and Goodwin 2017). 
This thesis will explain the US government’s bizarre conclusion in 1968 that, 
contrary to all available evidence, psychedelics were highly dangerous to society and 
had to be criminalized at the highest level. The primary objective of this project is to 
explain the rapid shift in public and governmental opinion in the US in the context of 
the global drug prohibition regime. The following sections draw extensively from the 
existing literature on the topic, and supplement that secondary source research with 
careful examination and synthesis of the available historical evidence. Based on this 
evidence, this paper will challenge the dominant theory—that American prohibition of 
psychedelics was the result of a “moral panic” sparked by media sensationalism. The 
final two sections will demonstrate that, although a moral panic did occur, the primary 
cause of psychedelic criminalization was not the panic. Instead, it was neo-Puritan, anti-
drug cultural norms, combined with a series of developments in the psychiatric research 




Section II discusses the methods used to collect and interpret evidence, as well 
as the limitations of the evidence and the study itself. Section III provides a brief 
overview of the key historical facts, to provide the reader with context for the 
argumentative portion of the thesis. Section IV proceeds to review the literature on 
psychedelic criminalization (including the moral panic theory), as well as drug 
criminalization in the US more generally. Section V addresses at length the moral panic 
theory of psychedelic criminalization, assessing both its strengths and its shortcomings. 
Finally, Section IV synthesizes the information from previous chapters into a cohesive 
theory, which incorporates the strongest elements of the moral panic theory while also 





A: Process Tracing 
In political science, establishing causal relationships is notoriously difficult. 
Political events may have hundreds of hidden, interrelated causes, none of which would 
have been enough to trigger the event on their own. Moreover, each specific political 
event only happens once—control groups and multiple trials are luxuries that the 
political scientist does not always enjoy. Therefore, theories in political science are built 
not only on statistics or experiments, but also on logical inference and careful 
argumentation. These arguments are supported by balanced and thorough investigation 
of the relevant historical facts. This is the approach used in this thesis—it applies a 
qualitative, process-tracing methodology to analyze the historical record and develop a 
theory to explain the global criminalization of psychedelics.  
 Before beginning the process-tracing step, it was necessary to develop a timeline 
of important developments, from the discovery of LSD in 1938 to the international 
prohibition of psychedelics in 1971. This timeline followed several interconnected 
sequences of events, which include: the early research and therapeutic use of 
psychedelics by the psychiatric community, the explosion of non-medical psychedelic 
use (including popular figures like Tim Leary who encouraged it), the association of 
psychedelics with the 1960s youth counterculture, and the evolving media 
representations of psychedelics through the 1950s and 60s. This timeline relied mainly 
on secondary literature, such as Lee and Shlain’s (1985) Acid Dreams and Stevens’s 
Storming Heaven: LSD and the American Dream (1987). Wherever possible, multiple 




corroborate key factual points. The results of this analysis are outlined in the Historical 
Background section. 
 After the timeline, several plausible hypotheses were assembled to explain each 
major development in the path to psychedelic prohibition. These hypotheses ranged 
from narrow, e.g. “Tim Leary’s testimony to the Senate in 1966 increased Senators’ 
distaste for psychedelics,” to broad, e.g. “When psychedelics were criminalized in 1968, 
most government officials believed they were legitimately dangerous.” Many of these 
hypotheses were drawn from existing secondary literature on the topic—these are 
described in the Literature Review section. Others were developed by closely 
examining the timeline and searching for plausible causal relationships. Once a range of 
reasonable explanations had been determined for each major development, they were 
evaluated against the primary source evidence.  
 In gathering primary sources, the focus was on the 1960s, when the popularity 
of psychedelic drugs hit its zenith—and when they were criminalized throughout the US 
and the world. Three main types of source were used. The first type was media 
representations of psychedelics, such as newspaper/magazine articles. The second type 
was governmental communications, such as the minutes from legislative hearings, 
public statements from government officials, and any private communications on the 
subject available. The third type was the scientific evidence available at the time, 
including safety and tolerability studies, research into psychedelics as psychiatric 
medications, and medical conference proceedings. Once collected, this primary source 




 The result of this process is a theoretical account of the criminalization of 
psychedelics. This account combines the best-supported hypotheses into a single, 
coherent narrative. Where appropriate, alternative hypotheses are explained and refuted. 
Most aspects of this theory are drawn from secondary literature on the history of 
psychedelics, as well as the larger body of work surrounding American drug politics in 
general. Primary source evidence is also used throughout the paper to substantiate and 
reinforce important historical points.  
B: Methodological Limitations 
1: Availability Bias 
 The use of primary source evidence was necessarily subject to some availability 
bias. It was only possible to consider primary-source evidence that exists and is publicly 
available. This increases the likelihood that certain factors were over- or 
underrepresented in the evidence base. For example, federal and state governments are 
disinclined to release information that would harm their public image, and this has had 
tangible impacts on this project. Much of the primary source evidence on the CIA’s 
psychedelic research program was purposefully destroyed in the 1970s, so it has been 
necessary to rely on secondary sources and the few primary reports that remain (Lee 
and Shlain 1985, 285). As another example, since magazine and newspaper articles are 
relatively easy to obtain, it has been difficult not to place disproportionate weight on 
media sources. 
Availability bias was addressed by carefully considering the quality and nature 
of evidence, not just the quantity available. The approach used in this thesis was 




Collier proposes a process-tracing method which categorizes all pieces of primary 
evidence as necessary, sufficient, both, or neither to confirm a particular hypothesis. 
The quantity of evidence is less important than the logical inferences that can be drawn 
from each clue. The evidence used here was also deliberately gathered from a balanced 
and diverse range of sources. The bulk of the primary source analysis was based on 
contemporaneous medical journals, mainstream news media, and government 
publications. However, the analysis also incorporates whatever evidence could be found 
from underground newspapers, declassified and/or leaked CIA documents, and other 
less-conventional sources. 
Of course, these measures may not have eliminated availability bias from this 
study. As with any historical investigation, this one is based on the limited, partial 
evidence that has survived the test of time. New evidence could emerge to contradict 
the narrative and theories presented here. If it does, then the conclusions of this thesis 
must be reevaluated. 
2: Selection Bias and Generalizability 
This thesis focuses almost entirely on the specific case of psychedelic 
criminalization in the US. Although it also examines the UN’s 1971 decision to include 
psychedelics in Schedule I of the Convention on Psychotropic Substances, that is done 
primarily to evaluate the role the US played in that decision. This is therefore a within-
case analysis—that is, it does not compare the causes of psychedelic criminalization in 
the US to the causes of psychedelic criminalization in other countries.  
Since this study considers only one case, there is substantial potential for 




Mahoney caution that within-case process tracing research is not generalizable to other 
cases, for two reasons (1996, 70-72). This is true for two main reasons. First, the 
researcher often chooses an extreme case to analyze, rather than a representative case. 
Indeed, this thesis focuses on the US partially for the sake of convenience and partially 
because the history of psychedelics in the US is dramatic and multi-faceted. So, the US 
may not necessarily be a good model through which to understand psychedelic 
criminalization in other nations. Second, even if the chosen case is not extreme, a 
qualitative, within-case analysis effectively amounts to a sample size of one—not near 
enough for a generalizable conclusion. In this work, these problems are addressed 
simply by making no claims of generalizability. The explanations provided here for 
psychedelic criminalization in the US do not necessarily shed light on the processes that 
led to psychedelic criminalization in other states.  
However, even without attempting to generalize, selection bias may still impact 
the results of this study. Collier and Mahoney note that studies focusing on a particular 
case or subset of cases may miss important relationships and patterns present in the 
complete set (1996, 63-64). That is, there may be hidden factors that contributed to 
psychedelic criminalization in the US, factors that only become apparent when the US 
case is compared to many other cases. Extensive comparative analysis is outside the 
scope of this study, so these hidden factors, if they exist, will have to be uncovered by 
future research. On the other hand, the depth of analysis provided by the process-tracing 





Therefore, although selection bias presents a significant limitation, the process-
tracing method was nevertheless the most effective way to investigate the research 






III: Historical Background 
The history of psychedelic use in the Americas dates back thousands of years. 
Since pre-historic times, naturally occurring psychedelics such as psilocybin 
mushrooms, mescaline-containing cacti, and ayahuasca brews have been used by Native 
tribes in North and South America (Frame n.d.; Kuhn et al. 121-128). To Indigenous 
users, these substances were not recreational; they were conduits to the divine. R. 
Gordon Wasson, the man who introduced psilocybin to white America, notes that 
“among the Indians, [psilocybin mushrooms’] use is hedged about with restrictions of 
many kinds . . . these are never sold in the marketplace, and no Indian dares to eat them 
frivolously, for excitement” (1957). By the late 19th century, white Americans had 
begun to experiment with peyote, and in 1897 chemist Arthur Heffter successfully 
isolated its psychedelic compound, mescaline (Frame, n.d.). But it was in 1938, at a 
laboratory in Switzerland, that the story of psychedelics in the US truly began. 
 A: Onset of Action 
In that Swiss laboratory, which belonged to the pharmaceutical company 
Sandoz, Albert Hoffman was attempting to synthesize a new headache medication from 
the ergot fungus. He produced a wide range of novel compounds, but none passed 
animal trials—among the discards was an unassuming molecule, lysergic acid 
diethylamide, which Hoffman labelled “LSD-25.” Five years later, in 1943, a “peculiar 
presentiment” convinced him to take another look at this chemical. In the process of 
resynthesizing it, Hoffman accidentally absorbed a microscopic amount through his 




Once the drug had worn off, it was clear to Hoffman that he had discovered 
something hugely significant. LSD was, by far, the most potent hallucinogen known to 
humanity. Sandoz spent several years attempting to determine what particular medical 
purpose it could serve. Ultimately, in 1947, Sandoz brought LSD to market under the 
brand name “Delysid.” They distributed large quantities free of charge to researchers in 
an attempt to discover what exactly LSD was good for, sparking a massive wave of 
research in the early 1950s (to be discussed later in this section) (Pollan 2018, 142-143). 
Sandoz encouraged psychiatrists to not only prescribe LSD for a range of mental 
disorders, but also to consume it themselves, so as to achieve a better understanding of 
the psychotic mind (Frame, n.d.). As Sandoz peddled their invention on the 
pharmaceutical market, however, another customer took notice—the US Central 
Intelligence Agency. 
B: Psychochemical Warfare 
Long before LSD was well-known among the American public, it was 
extensively tested by the US Army and the CIA. Since the beginning of the Cold War in 
the mid-1940s, the US had been keenly interested in discovering a “truth serum,” a 
substance that would render interrogees more malleable and likely to divulge secrets. 
Throughout the 1940s and 1950s the CIA conducted secret tests with cannabis, 
sedatives, and various combinations of other psychoactive substances (Lee and Shlain 
1985, 5-12). At some point in the late 1940s or early 1950s (the exact date is not public 
information), they discovered LSD. The agency began testing it extensively on their 
own operatives, as well as funding external psychiatric research (Lee and Shlain 1985, 




“better adapted than known drugs to both interrogation of prisoners and use against 
troops and civilians,” and lauding its “great strategic significance” (CIA 1954, 1).  
These promising results led the CIA to initiate a secret program in 1953, one so 
blatantly unethical and illegal that, even today, it remains a major stain on the agency’s 
reputation: Project MK-Ultra (Pollan 2018, 142). The goal of MK-Ultra was to test 
LSD’s usefulness in the field, which was achieved in part by secretly dosing random 
civilians with large quantities of LSD and then subjecting them to simulated 
interrogations. The CIA also tested LSD’s potential as a “brainwashing” agent on 
dozens of psychiatric patients, mostly racial minorities, without consent—a clear 
violation of the Nuremberg Code (Lee and Shlain 1985, 23-35). Internally, the CIA 
leadership justified their heinous acts with the classic Cold War refrain: if we do not, the 
Soviets will get there first (CIA 1954, 2; Lee and Shlain 1985, 27). In fact, Russia truly 
was engaged in a mind-control program of their own, although their focus was on 
electromagnetism rather than chemicals (Kernbach 2013). 
Excuses aside, let it be clear: the US government used LSD as an experimental 
instrument of torture on unsuspecting American citizens, many of whom had committed 
no crime. Although many sources sugar-coat these experiments with sanitized 
terminology, this downplays their abhorrence. According to the UN Convention against 
Torture, “torture” is defined as “any act by which severe pain or suffering, whether 
physical or mental, is intentionally inflicted on a person by . . . a public official or other 
person acting in an official capacity” (OHCR 1984). High doses of LSD, administered 
without consent, combined with aggressive interrogation tactics, certainly inflicted 




utility of psychedelic drugs was to “produce anxiety or terror” (Bimmerle 1993). In 
1963, the CIA’s Inspector General warned agents to take great pains to ensure that MK-
Ultra remained secret, lest the agency’s public image be ruined (Stevens 1987, 84). 
By 1958, the US Army had begun its own series of experiments on LSD as 
torture instrument. According to testimony by the Army’s General Counsel in 1975, 
these experiments were mainly conducted on a group of about 600 US soldiers (Ablard 
1975, 9, 15). One of these soldiers, a Black man named James Thornwell, was 
imprisoned and psychologically abused for three months, interrogated under the 
influence of a heavy dose of LSD, then released; mentally, he never recovered 
(Khatchadourian 2012). Apparently, the Army was satisfied with the results of their 
experiments, as LSD was then taken overseas and “field-tested” in the early 1960s 
(Ablard 1975, 12-14). This field testing entailed the detainment of “Orientals of various 
nationalities” who were suspected of Communist espionage or (ironically) drug 
trafficking (Khatchadourian 2012). These detainees were given massive doses of LSD 
in conjunction with more traditional torture methods like extreme temperatures and 
dehydration—several begged their interrogators for death (Lee and Shlain 1985, 39-40). 
Torture was not the only goal of the CIA and Army’s experiments with LSD. In 
1959, Major General William Creasy petitioned Congress to fund an Army 
“psychochemical warfare” project (Lee and Shlain 1985, 36-37). LSD and other 
hallucinogens could be an alternative to nuclear weapons, Creasy argued, if 
administered to an enemy population via the air or water supply (Ablard 1975, 4-5). 
While a city’s inhabitants wandered about in a hallucinatory delirium, Creasy believed, 




Congress approved Creasy’s proposal for a psychochemical warfare project, although 
LSD turned out to be too difficult to administer to large populations (Lee and Shlain 
1985, 36-37, 41). Instead, the Army moved on to more potent, easily administered 
superhallucinogens. One such weapon, BZ, was used in the Vietnam War and may have 
been considered for use against domestic insurgents (42-43).  
 None of the information in this section came to light until the mid-1970s, after 
the CIA had already purged most of the relevant evidence from its records (Lee and 
Shlain 1985, 285-286). But in hindsight, it is clear that nobody played a larger role in 
the early history of psychedelics in the US than its own military and intelligence 
agencies. The CIA not only provided tremendous resources to private researchers 
investigating LSD, but they also founded the first LSD production operation in the US 
(20-21, 27). Of course, the agents who authorized these decisions could not have known 
that this experimental truth serum would come to revolutionize psychiatry and fuel a 
cultural upheaval like the US had never seen. 
C: The Peak 
After LSD hit the market in 1947, in no small part thanks to the efforts of the 
CIA and US Army, it spread like wildfire throughout the American psychiatric 
community. Initially, due to reports from the CIA and Army, it was believed that LSD’s 
primary effect was to induce a temporary state of psychosis, and so it began to be 
dubbed a “psychotomimetic” (Lee and Shlain 1985, 19-21; Pollan 2018, 145-146). Even 
in 1951, however, there were those who believed it was something more. Chief among 
them was Al Hubbard, the “Johnny Appleseed of LSD.” Hubbard, after trying LSD in 




One of Hubbard’s close colleagues was psychiatrist Dr. Humphrey Osmond, 
with whom Hubbard worked to establish LSD treatment centers nationwide. These 
centers specialized in treating alcoholism and reported an astonishing 50% success rate 
(Lee and Shlain 1985, 45-50). In 1957, Osmond presented his results to the New York 
Academy of Sciences and spoke out against the “psychotomimetic” paradigm. The 
subjective effects of psychedelics, he contended, bore only a superficial resemblance to 
psychosis. Moreover, if all these drugs did was simulate mental illness, then how could 
they have such incredible therapeutic effects? (Pollan 2018, 150-151) Instead, Osmond 
proposed a new term for this novel class of substance, “psychedelic,” from the Greek 
for “mind-manifesting” (Lee and Shlain 1985, 55). Evidently, the term has persevered. 
Osmond’s research on psychedelics also succeeded in attracting the interest of 
famous author Aldous Huxley, who volunteered himself for a mescaline trial in 1953 
(Lee and Shlain 1985, 46). For Huxley, as for so many others before and after him, the 
psychedelic experience was life changing. A year later, he published a rapturous 
account of his trip: The Doors of Perception. “I was seeing what Adam had seen on the 
morning of his creation—the miracle, moment by moment, of naked existence” (Huxley 
1996, 17). It is hard to overstate the impact of this book—psychedelics were relatively 
unknown to the American public, and now one of the greatest writers of the generation 
was singing their praises! (Lee and Shlain 1985, 47; Siff 2015, 61) Huxley goes so far 
as to suggest an education system in which intellectuals are “urged and even, if 





 In large part due to Huxley’s evangelizing, public interest in psychedelics 
continued to mount throughout the 1950s. This process was accelerated by a 1957 
special in LIFE magazine entitled “Seeking the Magic Mushroom,” an account of 
businessman R. Gordon Wasson’s trip to Mexico to participate in an Indigenous 
mushroom ceremony. Like Huxley, Wasson was thrilled by his experience and even 
speculates that psilocybin mushroom experiences might have “planted in primitive man 
the very idea of god.” Wasson, together with Huxley, played a tremendous role in 
introducing psychedelics to the American public (Lee and Shlain 1985, 72; Siff 2015, 
73-86). By 1959, Americans from all walks of life were trying psychedelics for their 
medical benefits, the news media ran celebrity endorsements, and psychedelic therapists 
were widespread (Lee and Shlain 1985, 55-57; Siff 2015, 99-101). “By the end of the 
decade,” says Pollan, “LSD was widely regarded in North America as a cure for alcohol 
addiction” (2018, 151). Additionally, many artists followed Huxley’s advice to turn to 
psychedelics for inspiration. These included Beat generation pioneers Jack Kerouac and 
Allen Ginsberg, whose revolutionary poem “Howl” was directly inspired by a 
mescaline experience (Lee and Shlain 1985, 60-61, 80; Miles 2005, 68; Stevens 1987; 
113-114). 
 Among the many who took an interest in psychedelics after reading Wasson’s 
article in LIFE was Harvard psychology professor Tim Leary. Seeking insight into the 
workings of the human mind, Leary took a trip to Mexico in 1960 to try psilocybin 
mushrooms for himself (Stevens 1987, 122). He was stunned. To a friend he exclaimed, 
“I learned more in six hours than in the past sixteen years!” Later, in his book High 




world: “It will change your life! You will be reborn!” (133) Leary promptly returned to 
the states and launched the Harvard Psilocybin Project (Lee and Shlain 1985, 73-76). 
The project at Harvard conducted a range of controversial experiments, with a 
range of fascinating results—for example, in the 1962 “Miracle at Marsh Chapel,” 
churchgoers who ingested psilocybin before a service almost universally reported 
mystical experiences (Lee and Shlain 1985, 76-77; Stevens 1987, 168-169). Ultimately, 
however, Leary’s Harvard colleagues grew uncomfortable with his gung-ho approach to 
psychedelics, particularly his highly unprofessional habit of taking the drugs alongside 
his test subjects. After a scathing exposé in the Harvard Crimson, the Psilocybin Project 
was shut down by the FDA, and Leary was dismissed (Lee and Shlain 1985, 87-88). 
However, he went on to become the single most influential advocate for the spiritual 
use of psychedelics (Miles 2005, 68-72; Pollan 2018, 139-139). 
 The FDA did not stop with the Harvard Psilocybin Project in 1962—later that 
year, they imposed stringent new regulations on pharmaceutical research, and began to 
deny most applications to research psychedelics (Lee and Shlain 1985, 91). Few 
researchers had the will or resources to meet the new FDA standards, and psychedelic 
research sharply declined (Belouin and Henningfield 2018, 9; Carhart-Harris and 
Goodwin 2017). Then, in 1965, the Drug Abuse and Control Amendments formally 
banned the unlicensed manufacture or sale of LSD (Lee and Shlain 1985, 93). These 
Amendments provided the FDA with sweeping authority to enforce this provision and 
prosecute illicit manufacturers or sellers (Abramson 1966; NIH 1966, 9). The final nail 
in the coffin for researchers hoping to investigate LSD came in 1966, when Sandoz 




remaining (Schumach 1966; Stevens 1987, 281). But although legal psychedelic therapy 
and research was no longer possible, possession was not yet banned, and the 
recreational acid wave had just begun.  
1965 was the golden age for recreational psychedelic users. The Free Speech 
movement and hippie counterculture were in full swing, and the black market was 
saturated with illegally manufactured LSD (Lee and Shlain 1985, 126-127, 146-147). 
Iconic madcap author Ken Kesey and his band of “Merry Pranksters” roamed the 
country in technicolor van, dosing thousands with LSD in their “Electric Kool-Aid Acid 
Test” parties (Lee and Shlain 1985, 121; Miles 2005, 36, 48, 54). Folk legend Bob 
Dylan took to the stage and introduced the music world to a revolutionary, psychedelic-
inspired style that came to be known as “acid rock” (Lee and Shlain 1985, 137). Many 
other world-famous musicians, such as John Lennon and George Harrison of the 
Beatles and Syd Barrett of Pink Floyd, were similarly enamored with the drugs (Miles 
2005, 84, 166). On college campuses, the use of psychedelics surged (Lee and Shlain 
1985, 132). It seemed they were beginning to have a real impact on American society. 
But ultimately, the drug culture was a victim of its own success. 
D: The Comedown 
The FDA’s crackdown on psychedelic research in the early 1960s was not 
uncontroversial. Senator Robert Kennedy (D – NY) launched an inquiry into the FDA’s 
decisions in spring of 1966 (NIH 1966). “We have lost sight of the fact that [LSD] can 
be very, very helpful in our society if used properly,” he argued. Kennedy was speaking 




Shlain 1985, 93). Ultimately, the Senate Subcommittee on Juvenile Delinquency called 
a series of Senate hearings to discuss the problem of recreational psychedelic use. 
Among those who testified against criminalizing psychedelics were Beat poet 
Allen Ginsberg, Tim Leary, and Dr. Stanley Yolles, the former director of the National 
Institute of Mental Health (NIMH). Leary and Ginsberg were restrained, seeking a 
compromise between the extremes of total criminalization and unrestricted access (Lee 
and Shlain 1985, 150-153 ; Walsh 1966, 1729). “The commercial activities involving 
manufacture, sale and distribution of these substances definitely should be controlled,” 
conceded Leary, but “LSD is not a dangerous drug” (McNeill 1966). Dr. Yolles agreed 
that criminalization was unwise, observing that “the short-term effects of [psychedelic] 
treatment are sufficiently interesting to warrant continued support” (the role of Dr. 
Yolles and other medical experts in the criminalization process will be discussed at 
length in later sections) (NIH 1966, 22-33). Nevertheless, although the federal 
government held off, in May 1966, California formally banned the possession of LSD 
(Desert Sun 1966). 
If anything, prohibition in California only made LSD more popular. In January 
of 1967, members of the San Francisco counterculture hosted the first “Human Be-
In”—a massive gathering of hippies and psychedelic acolytes, with Tim Leary as the 
headline speaker. The resounding success of the event precipitated a frenzy of media 
attention (Lee and Shlain 1985, 162). Of course, the more the newspapers condemned 
the counterculture, the more attractive it seemed to rebellious youth nationwide. Young 




Area. By summertime, San Francisco was swarming with aspiring hippies; the Summer 
of Love had begun (Stevens 1987, 338-344).  
However, the streets of San Francisco were dangerous for lone teenagers, and as 
hapless prey flooded in, the city’s criminal element grew as well (Stevens 1987, 339). 
Many of the novice hippies also severely underestimated the intensity of the 
psychedelic experience. San Francisco hospitals admitted thousands of panicked youths 
in the midst of “bad trips” (341), This problem was exacerbated by black market sales 
of a long-lasting military super-hallucinogen called STP that was often disguised as 
LSD—even experienced psychedelic users sought medical help when what they 
assumed was acid still hadn’t worn off after three days (Lee and Shlain 1985, 187). For 
older hippies, the counterfeit drugs, naïve poseurs, rising crime rates, and police 
repression were too much to handle. On the one-year anniversary of LSD being banned 
in California—October 6, 1967—a mock funeral was held on Haight St. for the “death 
of the hippie,” and counterculture members of all stripes began leaving the Bay Area 
shortly afterward (191-192).  
About a year later, in 1968, possession of LSD was banned by the US federal 
government. In 1970, the new Controlled Substances Act classified LSD and other 
psychedelics as Schedule I, signifying that they had no medical potential and the highest 
possible potential for abuse (Lee and Shlain 1985, 93). The next year, through the UN 
Convention on Psychotropic Substances, psychedelics were placed in the strictest 
category, above cocaine and alongside heroin (Bayer 1989, 23). From 1970 to the 
2000s, the blanket bans on psychedelic possession made it nearly impossible for 




applications without explanation (Richert 2019, 90-91). Although there has been a 
recent revival of interest in the medical possibilities of psychedelics (see “Conclusion 
and Discussion”), they remain Schedule I illicit drugs in the US. So now we turn to the 
central question: why did this occur? The following section will explore current 




 IV: Literature Review 
The topic of drug criminalization has attracted significant scholarly attention 
from political scientists, sociologists, medical professionals, historians, and other 
interdisciplinary researchers. First, much has been written on the history of drugs and 
drug criminalization in the US. Second, there have been several investigations of 
psychedelic criminalization specifically. 
A: Drugs in the United States: Expanding Criminalization 
The substantial body of work on American drug history and policy has laid the 
theoretical groundwork for the more narrowly targeted analysis in this thesis. Over the 
past century, American drug policy has been characterized by increasingly harsh 
criminalization of illicit substances, epitomized by the so-called “War on Drugs.” Even 
in 1986, the New York Times recognized that the nation’s relationship with drugs was 
cyclical: periodically, the popularization of new drugs would spark a panic, and that 
panic would spur heightened criminalization (Kerr 1986). This cycle has ensured that, 
in the long run, the intensity of drug criminalization is continually ratcheted upward. 
In Policing the Globe, Andreas and Nadelmann compellingly argue that this 
pattern began in the early 20th century (2006, 40-41). In the 1800s, drug use was 
relatively widespread and accepted in the US—Brecher et al. (1972) note that use of 
opiates was considered a “vice akin to dancing, smoking, theater-going, gambling, or 
sexual promiscuity,” but was not cause for imprisonment. Cocaine was similarly 
accepted, and used in a wide variety of consumer goods, most famously in the original 
formulation of Coca Cola (Andreas and Nadelmann 2006, 40). However, Andreas and 




combined with substantial efforts by Protestant “moral entrepreneurs,” caused the US to 
begin criminalizing recreational substances in the early 1900s (40-41). 
In Morgan’s (1981) Drugs in America, this shift is explored in greater detail.  
Above all, Morgan blames the prevalence of opium use in the late 19th century. He 
argues that the addictive and sedative effects of opium contributed to public perceptions 
of drug users as intrinsically lazy and enslaved to their substance of choice (50, 60-63). 
Combined with racialized stereotypes of cocaine users, says Morgan, this fed a narrative 
that drug use was antithetical to social progress, and ought to be criminalized (60, 94, 
101). By the 1930s, this criminalization had begun in earnest, led by anti-drug fanatics 
such as Narcotics Division head Harry Anslinger (120-121). Public support for 
criminalization was based on the common belief that all illicit drugs were functionally 
equivalent—after 1914, any new drug had to “prove itself by the company it kept” (138, 
143). Anslinger took great advantage of this belief, successfully convincing the public 
in the late 1930s that cannabis, like opiates or cocaine, was highly addictive and 
dangerous, although there was no scientific evidence to suggest this was the case 
(Anslinger 1937; Goode and Ben-Yehuda 2009, 198-202). In the following years, 
concerns about growing rates of heroin use, as well as persistent fear-mongering by 
Anslinger and his contemporaries, led to a series of “tough-on-drugs” policies, 
including the 1951 Boggs Act and 1956 Narcotic Control Act (Morgan 1981, 145-148). 
The zeal of American moral crusaders extended far beyond the US’s borders. 
From 1909 on, say Andreas and Nadelmann, the US has prosecuted an international 
campaign of “exceptional scale and scope . . . drafting and lobbying for increasingly 




aspects of drug trafficking both internationally and in the domestic legislation of all 
[UN] member countries” (2006, 43). The culmination of these efforts was the 1961 UN 
Single Convention on Narcotic Drugs, which was largely modelled after US federal law 
and driven by US efforts (Andreas and Nadelmann, 43; Crick 2012, 408). Emily Crick 
argues that this convention marked a crucial turning point, legitimizing the 
representation of drug use as a national security issue and codifying the global 
prohibition regime (2012, 407). Sophie O’Manique concurs, noting that the US’s focus 
on drug policy in the international sphere reflects a belief that “drug trafficking . . . 
poses a threat to international security and human rights. In the discourse, drug 
traffickers become equated with terrorists” (2014, 49). 
The shift to a security framework evidently accelerated the expansion of the US 
drug criminalization regime. In the 1960s, in parallel with the psychedelic scare, public 
concern mounted over use of amphetamines, barbiturates, and cannabis by non-white 
Americans (Morgan 1981, 158-161). This culminated in the election of Richard Nixon, 
who called drug abuse “public enemy number 1” and dramatically intensified federal 
drug enforcement (Nixon 1971, Lee and Shlain 1985, 221). For Nixon, the issue was 
personal. He “felt a reflexive distaste for illegal drugs and the people who used them,” 
and fretted that cannabis and psychedelics were “turning a generation of Americans into 
long-haired, love-beaded, guru-worshipping peaceniks” (Massing 1998, 97). The cycle 
repeated in the early 1980s when soon-to-be President Ronald Reagan instigated 
another panic over drug use for electoral advantage, then dramatically escalated the 




The War on Drugs has achieved shockingly little success curbing drug use in the 
US—or in any other nation that has adopted harsh criminalization policies (The 
Economist 2018; Shultz and Aspe 2017). Degenhardt et al. (2008, 1065) observe that 
“countries with more stringent policies towards illegal drug use did not have lower 
levels of such drug use.” In fact, the US has the highest levels of all. Massing estimates 
that, by investing in treatment rather than law enforcement, the US could have achieved 
far better results at a fraction of the cost. “Every study of drug treatment has arrived at 
the same conclusion: . . . impressive reductions in both drug consumption and criminal 
activity, at a relatively low cost” (1998, 51). This is not a new concept—in 1975, a 
government task force produced an in-depth report critiquing American supply side 
drug policy and recommending a shift to a treatment-first paradigm. The Ford 
administration flatly ignored these results, however, opting instead to ratchet up 
paramilitary operations against opium growers in Mexico (Massing 1998, 135). With 
the notable exception of cannabis legalization in many states, the US’s drug 
criminalization regime has continued unabated to the present day (see “Conclusion and 
Discussion”). 
No discussion of drugs in the US can be complete without addressing race, 
which has been entwined with drug rhetoric from the beginning. As early as the turn of 
the 20th century, the news was pervaded by sensationalized tales of opium-smoking 
Chinese immigrants seducing white women and Black cocaine users going on furious 
rampages (Goode 2008, 536 ; Morone 2003, 464-466). Then, in the 1930s, Harry 
Anslinger’s anti-cannabis campaign heavily leveraged public fears of Mexican 




“what a small marihuana cigarette can do to one of our degenerate Spanish-speaking 
residents . . . most of who are low mentally” (Anslinger 1937). The racialization of the 
drug problem, and the resultant harm to communities of color, has only increased in the 
decades since. Kevin Gray argues compellingly that today, “for white America, the drug 
problem has a black face” (1998, 166). Particularly in federal courts, he notes, non-
white defendants are convicted of drug crimes at massively disproportionate rates (168). 
Once incarcerated, these individuals are forced to labor for meager wages, providing 
immense profits for the stakeholders of the prison-industrial complex (196). To fully 
examine the racial history of drugs in the US would require an entire additional thesis—
suffice it to say, the relationship between drug criminalization and racism features 
heavily in the literature base and is crucial to a complete understanding of drug policy. 
B: Psychedelic Criminalization: The Moral Panic Hypothesis 
Up until now, this section has explored the literature on American drug policy in 
general. It will now turn to the literature on psychedelic criminalization specifically, 
which is somewhat sparse, and almost invariably centers on the theory of “moral 
panics.” The theory of moral panic was first articulated in 1972 by Stanley Cohen in his 
seminal work Folk Devils and Moral Panics. He defines a moral panic as an abrupt 
explosion of public fear regarding a perceived “threat to societal values and interests” 
(9). This threat is nearly always blamed on a particular agent or group of agents, the 
“folk devils: visible reminders of what not to be” (10). Cohen devotes substantial 
attention to the role of the media—the media, he argues, play a dominant role in setting 
a nation’s moral agenda (16-17). Yet the media are incentivized to exaggerate and 




reporting—moral panics, says Cohen, begin with deliberate “news manufacturing” (44, 
46-48). 
In a 1994 article, Goode and Ben-Yehuda add further clarity to moral panic 
theory. They outline a set of specific criteria that can be used to determine whether an 
incident constitutes a moral panic. These include: public concern about a certain 
behavior; hostility towards those who practice the behavior; consensus among a 
significant portion of the population that a threat exists; disproportionality between the 
actual scale of the problem and the public response; and volatility, meaning the panic 
emerges suddenly and fades quickly (156-159).  
Debate about psychedelic criminalization has largely centered on moral panic 
theory. Goode and Ben-Yehuda point to LSD criminalization in the late 1960s as the 
result of an “unprecedented” moral panic (2009, 202). They cite sensationalist media 
accounts, which exaggerated and fabricated dangers of LSD use and demonized its 
proponents. “The media seized upon and reported the very small number of untoward 
LSD-related episodes . . . in the context of the 1960s, LSD ‘freak-outs’ were news; 
stories that LSD does not cause psychotic outbreaks were not news” (203). Goode and 
Ben-Yehuda believe, like Cohen, that the media’s self-interested cherry-picking of 
sensational information plays a crucial role in generating moral panics. “The media 
hysteria,” they conclude, “brought forth criminal legislation that penalized the 
possession and sale of LSD” (205). 
Media portrayals of psychedelics were later explored in much greater detail in 
Stephen Siff’s 2015 book, Acid Hype. Siff largely agrees with the moral panic 




media representations of psychedelics were out of touch with reality. In the 1950s, the 
media were quick to heap unearned praise on psychedelics, portraying them as potential 
wonder-drugs (Hyams 1959; Siff 2015, 61). But in the mid-1960s, when public 
concerns about the dangers of psychedelics were growing, media outlets capitalized on 
the fear by publishing unsubstantiated negative reports about the substances (Siff 2015, 
151). This instigated a feedback loop of bad press and negative public response, 
culminating in the late 1960s’ moral panic (177).   
Another variant on the moral panic hypothesis was proposed by Miranda 
DiPaolo in 2018. DiPaolo takes the moral panic hypothesis as a starting point but argues 
that the panic did not emerge organically, or as the simple result of media 
sensationalism. Rather, she claims, criminalization of LSD was a purposeful 
government effort to persecute the hippie counterculture of the 1960s. She points to the 
extensive history of aggressive police action against the hippie community (discussed in 
greater detail by Barry Miles in his 2003 book Hippie). The hippies were seen as a 
threat to the “national character,” argues DiPaolo, and their association with 
psychedelic drugs was a convenient avenue through which to cement their public image 
as deviant and criminal. This argument will be considered at greater length in the next 
section. 
In 2002, Cornwell and Linders published a direct rebuttal to the moral panic 
hypothesis, singling out Goode and Ben-Yehuda’s study in particular. Cornwell and 
Linders’s primary objective in their essay is to discredit moral panic theory as a whole, 
claiming that “the moral panic concept serves as an analytical distraction of sorts rather 




account of LSD prohibition. They argue that despite the media hysteria, criminalization 
of LSD was a slow process, characterized by cooperation and deliberation—not 
typically associated with a “panic” (308). Cohen’s entire theory of moral panic, say 
Cornwell and Linders, is based on the inaccurate assumption that people respond 
selfishly and irrationally in crisis situations like natural disasters. In fact, Cornwell and 
Linders claim, this sort of breakdown in social relations rarely occurs. In crises, natural 
or moral, people tend to cooperate and respond in an organized fashion (311-313). 
Cornwell and Linders also argue that moral panic theory reduces the public to gullible, 
passive media-consumers, and reduces the “folk devils” to mere objects of 
demonization. Cornwell and Linders contend that both the public and the “folk devils” 
play more active roles in the public conversation. Tim Leary, for example, was 
undoubtedly demonized by the government and media, but also was highly influential 
in shaping the public’s views of psychedelics (323-325). 
Goode wrote a piece in 2008 to defend his argument against Cornwell and 
Linders’s attack. Moral panics, Goode says, are a frequent occurrence, particularly 
surrounding drugs. He argues that Cornwell and Linders misunderstand moral panic 
theory. A moral panic is clearly not identical to the literal panics that occur in disaster 
situations, such as fires; Cohen’s disaster analogy was meant to be somewhat loose. 
Goode then provides extensive evidence that the media and public response to LSD in 
the 1960s was disproportionate to the actual threat the drug posed—the main indicator 
of a moral panic. This evidence includes the spate of factually untrue reports of 




“scourge,” “epidemic,” “crazed,” and “cult” in 1960s reports on psychedelics by the 
media (538-540, 542). 
Up to this point, this section has presented the views of various authors without 
commentary. However, the debate between Cornwell and Linders and Goode requires 
some clarification. Nowhere else in the literature base is the question of psychedelic 
criminalization debated so explicitly and thoroughly. However, the debate is muddied 
on both sides by substantial mischaracterization of the opposition. Cornwell and 
Linders, for their part, are far too focused on Cohen’s disaster analogy, which Goode 
accurately observes is by no means essential to moral panic theory (Goode 2008, 540-
541). Additionally, contrary to Cornwell and Linders’s characterization, Cohen quite 
clearly explains that in the aftermath of a disaster or a moral panic, social relations do 
not break down, and in fact play a major role in determining the response (1972, 22-24).  
Goode’s response, meanwhile, completely misses the thrust of Cornwell and 
Linders’s essay and responds to a straw man argument instead. Cornwell and Linders 
agree with him that the media and public response to psychedelics in the 1960s was 
disproportionate (2002, 319-320). Their point of contention is largely semantic; they 
use the example of LSD criminalization to illustrate that the process of deviance 
construction is slow, deliberative, and cooperative, and therefore should not be called a 
“panic” (308). Goode’s response does not substantially address these points, but instead 
focuses on reasserting the disproportionality of the response to psychedelics, which 
Cornwell and Linders had never disputed (Goode 2008, 538-540). Ultimately, both 




public response to psychedelics in the 1960s, disproportionate to actual harms, which 
led the US to criminalize them after a period of deliberation.  
In the following section, the moral panic hypothesis will be examined and 
evaluated against the historical facts. Layers of analysis will also be added to explain 
gaps in current theories. Conspicuously absent from prior works is an explanation of 
how the moral panic in the US, if it occurred, relates to the 1971 global prohibition of 
psychedelics by the UN. Also absent is a clear summary of the scientific evidence 
available at the time of criminalization—this is key to determine whether the public 




V: Did a Moral Panic Cause Psychedelic Criminalization? 
As explained in the literature review section, the criminalization of psychedelics 
has almost always been blamed on a moral panic. But does this theory hold up under 
scrutiny? There are two key questions: first, was there a moral panic in the US about 
psychedelics in the 1960s? There is abundant evidence to suggest there was. The public 
response was disproportionate to the problem, and made “folk devils” out of 
psychedelic researchers (e.g. Tim Leary) and users. Second, was this moral panic the 
cause of psychedelic criminalization? That is, would psychedelics have remained legal 
if the moral panic had not occurred when it did? This question is harder, but a careful 
review of the evidence suggests that the moral panic was, at most, a proximate cause of 
psychedelic criminalization. The US government and the UN were already beginning to 
contemplate criminalization before the moral panic began. Although the panic may have 
added urgency to these efforts, it is likely that psychedelics would have been 
criminalized regardless. 
A: Was There a Moral Panic? 
 If there were in fact a moral panic about psychedelics in the 1960s, what clues 
would be expected? Recall from the Literature Review that one of the primary 
indicators of moral panic is a sudden surge in public attention paid to a problem, 
disproportionate to its real scale. Also recall that moral panics generally entail the media 
portrayal of certain individuals or groups associated with the problem as “folk devils:” 
scapegoats for public rage and fear. Both of these factors were evident in the 1960s 




1: Disproportionate Reaction 
 To establish that public attention was disproportionate to the actual scale of the 
psychedelic problem, it is necessary to evaluate what was known to science at the time. 
If the evidence legitimately seemed to suggest that psychedelics were highly dangerous, 
then the reaction may not have been disproportionate to the apparent threat. However, 
this was not the case. A massive meta-analysis by esteemed LSD researcher Sidney 
Cohen, analyzing over 25,000 therapy sessions, reported in 1960 that “untoward events 
occurring in connection with the experimental or therapeutic use of the hallucinogens 
have been surprisingly infrequent . . . no instance of serious, prolonged physical side 
effects was found” (Cohen 1960, 30). He concludes that “with proper precautions 
[psychedelics] are safe” (39). No analysis emerged in the 1960s to challenge Cohen’s 
reults (Stevens 1987, 181).  
 Not only were psychedelics known to be safe, but most published evidence 
suggested that they had immense medical potential. In a 1957 experiment, LSD therapy 
was administered to fifty institutionalized patients with treatment-resistant neuroticism. 
Of those patients, forty-five reported significant improvement, and thirty-six were still 
improved two years after the LSD session (Martin 1957). A 1965 assessment of the 
research-to-date on psychedelic therapy found that “LSD has been found to facilitate 
improvement in patients covering the complete spectrum of neurotic, psychosomatic, 
and character disorders” (Mogar 1965, 157). Many psychiatrists were dubious of such 
results, as will be discussed in the next section. However, based on actual, published 
studies, an objective observer in the mid-1960s would conclude that psychedelics were 




However, an observer who based their opinions on newspapers and magazines 
would come to a very different conclusion. Stanley Cohen and other moral panic 
theorists (see “Literature Review”) emphasize the media’s tendency to blow threats out 
of proportion (Cohen 1972, 32-33). Indeed, after the 1966 Senate hearings brought 
psychedelics into the public eye, the news media produced a non-stop barrage of horror 
stories. These ranged from garden-variety freakouts, to teens blinding themselves by 
staring at the sun under the influence, to LSD-crazed murderers, to vague and 
overblown claims about the dangers of psychedelics (“more dangerous than heroin!”) 
(Siff 2015, 151-155). There are several clues that these stories were exaggerated, if not 
outright fabricated. For one thing, even as newspapers were flooded with such accounts, 
psychedelic-related hospital visits and arrests remained uncommon (Stevens 1987, 275-
276). Another strong hint is provided by the Netherlands today, where hundreds of 
thousands of doses of psilocybin are legally sold every year; Dutch authorities report 
that psychedelic-related accidents and disturbances are “extremely rare” (Huber n.d.). 
Nevertheless, searching for “LSD” in the archives of the New York Times and 
Los Angeles Times reveals dozens of sensational headlines from the late 1960s, 
including “Damage to Mind from LSD Feared,” “Slaying Suspect Tells of LSD Spree,” 
“LSD Victim Felt He Was Devil Stealing Souls,” “LSD Linked to Dead Youth,” 
“Victim of LSD Starts Long Return Trip,” and merely “Beware of LSD!” (NYT 1963; 
NYT 1966; Dreyfuss 1967; NYT 1971; Torgerson 1967; Winkler 1960). Psychedelics 
were “the nation’s newest scourge,” and users’ minds were “disintegrating under the 




1966 cover story about LSD: “The Exploding Threat of the Mind Drug That Got Out of 
Control” (Life 1966).  
In addition to the usual spate of uncorroborated horror stories, the authors of the 
Life special fret that psychedelics can “can convince those with criminal propensities 
that they are above the law” (Life 1966). This provocative claim is quite consistent with 
moral panic theory. In their 2009 work on moral panics, Goode and Ben-Yehuda 
observe a pattern: “new drugs are usually . . . attributed with a criminogenic effect – 
that is, many more people than is normally the case believe that they cause violence and 
crime” (2009, 198). Vatz and Weinberg examine this misperception extensively, noting 
that in fact, “drug-related crime is obviously more closely tied to . . . the criminal black 
market than to the chemical effects of the drugs. . . it is largely their illegality that 
makes them dangerous” (1998, 61-78). Of course, that is not to say that drugs cannot be 
conducive to criminal behavior. Michael Massing notes that, although many drug-
related crimes are attributable to prohibition, some are indeed caused by the drugs 
themselves. For example, stimulants like cocaine may loosen users’ inhibitions and 
promote violent behavior, and addictive drugs may drive their users to theft to fuel their 
habit. 
However, in the case of psychedelics, the criminogenic effect was illusory. 
Contemporary research suggests that psychedelic use is associated with less criminal 
behavior, not more (Hendricks 2014; Hendricks 2017). In the context of moral panic 
theory, the conflation of psychedelic use with crime is an excellent example of what 
Cohen (1972) calls “spurious attribution.” During a moral panic, a deviant group (e.g. 




This aids their transformation into living stereotypes, symbols of public fear— “folk 
devils” (44).  
2: The Hippies as Folk Devils 
The “folk devil” phenomenon can be seen quite clearly in the way mainstream 
America reacted to the “hippie” counterculture. Miranda DiPaolo (2018) argues 
convincingly that the moral panic of the 1960s, while ostensibly focused on psychedelic 
drugs, likely had much to do with their users: “young adults who fervently promoted 
views of unconventionality, sexual liberation, and constructive dissent.” DiPaolo takes 
the argument a bit too far—there is no evidence to suggest that psychedelics were 
banned as a purposeful attempt to persecute the hippie population, as she claims (see 
“Literature Review”). Indeed, the FDA crackdown on psychedelic research largely 
predated the hippie movement. However, the hippies’ role in the 1960s moral panic 
cannot be overstated. 
The hippie movement achieved mass notoriety in the aftermath of the First 
Human Be-In in 1967 (see “Historical Background”) (Lee and Shlain 1985, 163-164). 
There were many reasons the hippies were frightening to “respectable” mainstream 
American society. Perhaps the most obvious was their commitment to “sexual 
liberation,” which conservative Christians saw as nothing less than an all-out assault on 
American moral values (Miles 2005, 273-274). Hippies also ruffled feathers with their 
opposition to the Vietnam War, and their association with the left wing and the peace 
movement (Lee and Shlain 1985, 194). This association may not have been entirely fair 
to the leftists and peace activists—many of them were scornful of hippies, whom they 




political activism just another form of selling out to “the Establishment” (Lee and 
Shlain 1985, 165-167). However, there was substantial overlap between the two groups. 
The Youth International Party (“Yippies”) was a substantial force in late 1960s peace 
activism, but was also composed of die-hard hippies, whose primary political aims were 
free love and “acid for all!” (206, 215) 
Per Cohen, moral panics often lead to extreme, preemptive policing of the “folk 
devils” (1972, 86-87). In this case, public fear about the hippie movement translated 
into hyperaggressive police action against their events and communities. Writing in 
1969, Brown argues that hippies in San Francisco faced not merely criminal law 
enforcement, but a form of “social control as terror.” By this, he refers to unlawful raids 
on hippie residences, insulting billboards, and unjust arrests. Worst of all were the 
“street sweeps” in hippie gathering areas: “club-wielding policemen . . . closed exits 
from the assaulted area and then began systematically to beat and arrest those who were 
trapped” (Brown 1969). Arrests were generally based on vague or trumped-up charges; 
anyone without a draft card on their person could easily be detained as a “suspected 
draft dodger,” for example (Miles 2005, 211).  
Ironically, it was the hippies who protested against violence that faced the most 
of it. In October 1967, peace activists staged a mass protest at the Lincoln Memorial, 
famously stuffing soldiers’ rifle barrels with daisies. Of course, flower power did not 
protect them from being savagely beaten and arrested (Lee and Shlain 1985, 202-204). 
Yippies protesting in Chicago a year later were attacked not only by the local police, but 
the National Guard and the Army as well (219). The brutality and overkill of Chicago’s 




Yippies were partially responsible for their negative image, with their radical stunts and 
inflammatory threats to put LSD in the water supply, seduce politicians’ wives, and 
“burn Chicago to the ground” (215). They were so successful at terrifying mainstream 
America that even massively disproportionate response seemed justified—the hallmark 
of a moral panic.  
3: Weaponizing the Law 
The federal government was quite conscious of the ties between the hippie 
movement and psychedelic drugs. A 1967 FDA report on LSD asserts that “for many of 
the ‘hippy’ groups . . . [LSD] provides an easy and automatic means to membership . . .  
allegiance to drug values is regarded as a ‘loyalty test’” (Smith 1967, 14). Once 
psychedelics were illegal, politicians had a convenient excuse to ramp up law 
enforcement harassment of hippies. Cannabis laws had already been used extensively to 
criminalize hippie communities, even while “respectable” middle-class white 
Americans could smoke pot with relative impunity (Morgan 1981, 158, 161). In the late 
1960s, and early 1970s, the federal government made extensive use of drug laws, 
particularly the new psychedelic ban, to target hippies, anti-war protestors, and other 
leftists. 
This was not so much 1984-style totalitarianism as the fulfillment of a campaign 
promise. Nixon had ridden into office on the tide of moral panic. After the 1968 
Chicago protests, he was able to capitalize on public fear via a “law and order” 
campaign, promising to eradicate the “hippie freaks” (Lee and Shlain 1985, 221). Under 
his administration, the CIA expanded its domestic spying operation, as well as its 




hippies was heavily entwined with his crackdown on drugs (see “Literature Review”). 
In a top-secret internal memo, Nixon’s FBI Chief Edgar Hoover advised his agents, 
“since the use of . . . narcotics is widespread among members of the New Left, you 
should be on the alert for opportunities to have them arrested on drug charges” (Lee and 
Shlain 1985, 225). Evidently, such opportunities were plentiful; in the early 1970s, 
myriad anti-war organizers and counterculture figures (including Tim Leary himself) 
were served draconian sentences for possessing small quantities of psychedelics or 
cannabis (225-226). 
By the time the crackdown started, however, the moral panic over psychedelics 
was effectively over (Siff 2015, 185). The media had turned to fear-mongering over 
other drugs, with encouragement from Nixon’s PR team (182). This illustrates another 
of the key characteristics of a moral panic, as explained by Goode and Ben-Yehuda 
(1994): volatility. Even if it leaves a long-lasting institutional legacy, the panic itself is 
quick to emerge and quick to die out (158-159). From the initial media firestorm after 
the 1966 Senate hearings, until public attention shifted to other drugs after Nixon’s 
election, the moral panic over psychedelics lasted a mere three years. 
B: Did the Moral Panic Cause Criminalization? 
Having determined that there was indeed a moral panic in the late 1960s about 
psychedelics, it is now necessary to evaluate whether it was the main cause of 
psychedelic criminalization. If it were, what historical evidence should be expected? 
First, the government would be relatively uninterested in the problem until the moral 
panic began—obviously, if the government was already planning to ban psychedelics 




relatively rapid government reaction, without measured evaluation of the available 
evidence, as is typical of legislation designed to address moral panics. Third, if the 
moral panic caused international criminalization, criminalization of psychedelics would 
probably occur first in the US, and the international community would follow suit. If 
many other countries independently chose to criminalize psychedelics, it is unlikely that 
the US moral panic was the primary cause. The evidence does not seem to bear out any 
of these criteria, implying that the criminalization of psychedelics was not exclusively 
the result of the 1960s moral panic. 
1: Did Moral Panic Precede Government Action? 
The first criterion is easily disproven, as the government had been moving in the 
direction of criminalization for years when the moral panic erupted. Most scholars place 
the beginning of the panic in mid-1966 (Siff 2015, 151; Stevens 1987, 273-274). As 
explained in the previous subsection, this was after the spring Senate hearings 
discussing LSD criminalization. The government had already begun to seriously 
consider criminalizing psychedelics by the time that the media seized on the issue. 
That is not to say that psychedelics received no press before the Senate hearings, 
but the coverage was more balanced. A legal scholar writing in 1966 noted that, ever 
since the Harvard Psilocybin Project was shut down in 1963, “an alarmist press fanned . 
. . artificially created hysteria” (Rosborough 1966, 313). Although this may be true, 
there were also many positive reports, perhaps equally exaggerated, such as a 1964 
article in Horizon magazine, “Can This Drug Enlarge Man’s Mind?” (Siff 2015, 139-
141) Stephen Siff writes that “LSD was on the media agenda in the early 1960s, but as a 




government response” (141) Additionally, prior to the Senate hearings, the general 
public was relatively unworried about psychedelics. A 1964 Gallup poll asked 
Americans to name the nation’s most pressing problems, and only 2% brought up drugs 
(142). Although the media was beginning to take a stronger interest in psychedelics, 
most Americans did not consider them a major concern until the mid-1960s. 
This strongly suggests that the moral panic had not begun in earnest until the 
Senate was already contemplating criminalization. Moreover, it was years after the 
FDA began to crack down on psychedelic research in 1962, and again in 1965 (see 
“Historical Background”). Admittedly, it is quite possible that the moral panic 
accelerated the decision to criminalize psychedelic drugs. Considering the timeline, 
however, one is inclined to agree with Siff, who argues that “quite likely, state and 
federal officials would have acted the same way against LSD even had it not been 
discussed so frequently and at such length in the news” (2015, 177). 
2: Was the Criminalization Process “Panicked?”  
The second criterion also does not hold up under scrutiny. Cohen observes that 
when moral panics result in legislative changes, the changes are usually enacted 
quickly, framed as “emergency” measures, and primarily inspired by public outcry 
rather than genuine consideration of the issue (1972, 133-138). Cornwell and Linders 
(2002) argue, rightly so, that the process of psychedelic criminalization was far more 
measured and deliberate than would be expected if legislators had been caught up in a 
moral panic (see “Literature Review”).  
At the 1966 Senate Hearings, although the debate was heated, the Senators spent 




proponents of psychedelics, such as Tim Leary and Allen Ginsberg (NIH 1966). A 
contemporaneous observer notes that “the not unfriendly confrontation” between 
Ginsberg and the Senators “reflected a congressional attempt to understand the new 
problems about which it is legislating” (Walsh 1966, 1729). Additionally, at least some 
of the Senators seemed well-aware of the media’s propensity to exaggerate. Senator 
Kennedy noted that LSD is “not as widely used amongst our university students and 
amongst the rest of our population as has sometimes been reported” (NIH 1966, 47). 
Senator Abraham Ribicoff (D – CT) encouraged his colleagues “to strike a balance and 
not to throw overboard those elements of a drug that may be good because there are 
certain elements that are bad” (65). Clearly, the Senators were not blindly following the 
media narrative of the late 1960s. 
3: Did the US Spearhead International Criminalization? 
The final criterion relates to the international community’s condemnation of 
psychedelics in the 1960s. If a moral panic, instigated by the American news media, 
was the primary cause, then one would expect the US to have led the charge to 
criminalize psychedelics worldwide. It would not be the first time a moral panic in the 
US translated into international law. The US was the dominant architect of the 1961 
Convention on Narcotic Drugs and has been a key player in constructing the global drug 
prohibition regime (see “Literature Review”) (O’Manique 2014, 36-38). 
However, in the case of psychedelics, the US did not play such a role. The UN 
and W.H.O. had been debating psychedelics since 1963, well before the moral panic in 
the US began (Bayer 1989, 5). In August 1966, a Special Committee was convened to 




showing signs of such spread as to demand immediate action” (7). Certainly, the 
decision to create the Special Committee was related to the sudden flood of negative 
press from the American media. However, there is no reason to believe that the 
Committee’s official decisions were based on magazine articles. Unlike Congress, the 
Committee was not accountable to the American public, and so would have seen no 
need to assuage their fears with unnecessary policies. 
By January 1968, the UN’s Commission on Narcotic Drugs had unanimously 
agreed that the strictest possible controls should be imposed on psychedelics. Some 
nations, including the USSR, India, and Ghana, called to ban psychedelics immediately 
through amendment of the 1961 Convention. However, most countries opposed such a 
rapid move, the US included. Instead, the next several years were spent developing the 
new Convention on Psychotropic Substances, which regulated psychedelics as well as 
prescription stimulants and sedatives. (Bayer 1989, 8-9) 
When the Convention passed in 1971, Psychedelics were placed in Schedule I, 
the strictest category. This aligned with the advice of the W.H.O., who reported that 
psychedelics posed “an especially serious risk to public health and . . . they have very 
limited, if any, therapeutic usefulness” (Bayer 1989, 15). The US was one of the only 
nations to challenge this move, as it objected to international control of mescaline cacti 
(23). This history makes it clear that, if anything, the US dragged its feet on the 
inclusion of psychedelics into the global drug prohibition regime. Multiple times, in 
1968, and then again in 1971, the US explicitly opposed the wishes of anti-psychedelic 
hardliners in other nations. If an American moral panic were the root cause of global 




Certainly, there was a moral panic in the US about psychedelics, as all the 
classic signs (disproportionate response, media hysteria, and hyper-criminalized folk 
devils) are present. However, the moral panic hypothesis cannot convincingly explain 
criminalization in the US or abroad, for three key reasons. First, the US government 
was already preparing to ban psychedelics before the moral panic began. Second, the 
process of criminalization was too slow and deliberative to be the result of moral panic. 
Finally, rather than leading the international community to ban psychedelics, the US 
took a relatively moderate position in UN deliberations. Explaining why other countries 
were even more vehemently opposed to psychedelics than the US is largely beyond the 
scope of this thesis (see “Methods: Selection Bias and Generalizability”). However, the 
next section will develop an alternative theory to explain why psychedelics were 




V: An Alternative Theory of Criminalization 
Having examined the moral panic hypothesis and found it insufficient to explain 
the criminalization of psychedelics, this thesis will conclude with an alternative theory. 
This theory, like the moral panic hypothesis, is constructionist, positing that psychedelic 
use was deviantized due to socially constructed notions of morality, rather than 
objective risks. As previously discussed, there was a preexisting moral aversion to drug 
use in the American cultural consciousness, dating back to Prohibition-era moral 
crusaders (see “Literature Review: Expanding Criminalization”). In this moral 
framework, objective risk is less important than medical potential for determining a 
drug’s legal status. By the early 1960s, the mainstream psychiatric community had 
concluded that psychedelics were not suitable for medical use. Viewed through the anti-
drug moral lens, lawmakers saw this alone as sufficient reason to criminalize them.   
A: The Disenchantment of the Psychiatric Community 
Based on the published evidence available in the early 1960s, psychedelics 
appeared to be quite safe and medically promising (see “Was There a Moral Panic?”). 
Yet, at the time, most psychiatrists were unconvinced by the body of medical research. 
In the early to mid-1960s, the psychiatric community came to largely reject 
psychedelics as a potential treatment. This was in part due to legitimate concerns about 
their safety, spurred by the early association of the drugs with military and intelligence 
operations, anecdotal reports of adverse reactions, and fears of genetic damage. It also 
reflects the professional biases of many psychiatrists, for whom altered states of 




1: Safety Concerns 
The primary reason that medical professionals turned against psychedelics was 
the perception that they were dangerous. At the 1966 Senate hearings, former director 
of the NIMH Dr. Yolles remarked that using them was like “playing chemical Russian 
roulette” (NIH 1966, 38). Although it was hard to deny that psychedelics were 
remarkably non-toxic, other concerns were not so easily dismissed. Chief among them 
was the notion that, as Dr. Keith Ditman argued at the 1967 NIMH Conference, 
psychedelics were “psychologically toxic” (Meyer 1967, 27). The theory that 
psychedelics often trigger psychosis, although largely incorrect, gained traction as 
recreational users began showing up in emergency rooms in the early 1960s. These 
fears were compounded by research in the late 1960s which seemed to link LSD to 
genetic damage.  
Psychedelics were, to some extent, set up for failure by their early association 
with the military and CIA. Through their experiments, the CIA concluded that LSD was 
“extremely dangerous,” as it induced psychosis and terror (Lee and Shlain 1985, 85). 
They pushed this narrative relentlessly on the psychiatric community, including at the 
first international conference on psychedelics in 1959, which was chaired by a CIA and 
Army consultant, Dr. Paul Hoch (68-70). It is not surprising that the CIA and Army 
observed high rates of adverse psychological reactions. The effects of psychedelics, 
unlike most drugs, are highly dependent on the environment, mindset, and expectations 
of the user (Bunce 1979; Lee and Shlain 1985, 200). Taking a psychedelic drug, say Lee 
and Shlain, “reinforces and magnifies whatever is already in [the user’s] head” (1985, 




mysticism, and other glowing reports—tended to have positive, enlightening 
experiences with the drugs (Becker 1967). By contrast, non-consenting CIA test 
subjects, who underwent brutal interrogation methods and were told they were going 
insane, predictably experienced panic and temporary psychosis (see “Historical 
Background: Psychochemical Warfare”) (Lee and Shlain 1985, 69-70).  
The CIA’s initial reports of psychedelic-induced psychosis were seemingly 
corroborated in the early 1960s, as emergency rooms saw an influx of panicked, 
apparently psychotic patients under the influence of psychedelics (Pollan 2018, 209). 
By 1967, a doctor from Bellevue Hospital in New York reported admitting about two 
patients per week “for whom we feel that the LSD experience played, at the very least, a 
precipitating role in the admission” (Meyer 1967, 21). Of course, it had already been 
established by Cohen in 1960 that true psychotic reactions to psychedelics are very rare 
(35-36). But to many practicing doctors, it appeared that psychedelics were triggering 
psychotic breaks left and right. How can the disconnect between the objective research 
and medical professionals’ anecdotal experience be explained? 
Some of these emergency room cases may have been legitimate psychotic 
reactions; it is still not clear whether psychedelics can actually cause psychosis. 
However, current research suggests they do not—a recent study of 130,000 US adults 
“failed to find evidence that psychedelic use is an independent risk factor for mental 
health problems” (Johansen and Krebs 2015). If the risk of psychedelic-induced 
psychosis exists at all, it is miniscule, affecting somewhere around 0.2% of users, 
comparable to other psychiatric medications (Cohen 1960, 35-36; Kuhn et al. 2019, 




may have already been predisposed to psychosis, due to undiagnosed underlying 
conditions like schizophrenia (Anastasopoulos and Photiades 1962; Kuhn et al. 2019, 
139).  Most likely, the overwhelming majority of the patients admitted for supposed 
psychedelic-induced psychosis in the 1960s were merely having “bad trips,” (see 
glossary) and experienced no lasting negative effects once the drug wore off (Pollan 
2018, 209-210).  
The psychiatric community’s concerns about psychedelic-induced psychosis 
may have stemmed in part from the post-hoc fallacy—the tendency to assume that, 
because event Y followed event X, X caused Y. Psychedelics were exciting and new, 
and the psychedelic experience was intense, so users and medical professionals alike 
were quick to dubiously attribute any subsequent changes in the user’s state to the drug. 
Sidney Cohen observes this effect in his landmark 1960 meta-analysis. He describes 
patients complaining that their sessions of LSD therapy had caused side effects ranging 
from migraines to influenza to paraplegia. However, “it so happened that these people 
were all in the control group and had received nothing but tap water” (38).  
Examples of the post-hoc fallacy permeate the minutes of the 1967 NIMH 
conference on psychedelics. One of the more observant doctors noted that, upon 
examination, many ostensible acid casualties “turn out to be people with problems that 
have existed prior to LSD ingestion, but LSD becomes the diagnosis or the excuse” 
(Meyer 1967, 31). Indeed, many others at the conference were eager to draw general, 
causal conclusions from very limited evidence, such as case studies and anecdotes, and 
to overlook confounding factors. For example, one doctor referenced a patient he 




patient had already suffered from occasional psychotic episodes before ever touching 
psychedelics (13). Faulty inferences like this one may partially explain why so many 
experts believed psychedelics often induced psychotic reactions. This belief dissuaded 
most respectable psychiatrists from prescribing or researching psychedelics (Pollan 
2018, 209). 
Concerns about the safety of psychedelic drugs were compounded in 1967, 
when a paper in Science reported that, in a test tube, exposure to LSD damaged 
chromosomes (Siff 2015, 155). Coming when it did, at the height of the psychedelic-
related moral panic, the media quickly seized on this discovery (Blakeslee 1970). “If 
you take LSD even once,” warned the Saturday Evening Post, “your children may be 
born malformed” (Siff 2015, 156). These conclusions were clearly overstated; for one 
thing, chromosome breakages do not necessarily cause birth defects, and there were no 
examples of LSD-damaged infants (Goode and Ben-Yehuda 2009, 204; Siff 2015, 156-
157). Indeed, at the 1967 NIMH conference, where the chromosome issue was 
discussed extensively, several doctors observed that among Indigenous tribes and hippie 
communities who used psychedelics extensively, there were no more birth defects than 
normal (Meyer 1967, 2-4, 50). Additionally, at high concentrations in a test tube, many 
benign substances, such as caffeine, can also damage chromosomes. That does not 
mean they do so in living humans (Lee and Shlain 1985, 154-155). “For the data that we 
have in the in vivo study,” said Dr. Charles Shagass at the NIMH conference, “the 
results suggest that not much is happening. The fact that in vitro and in vivo data are 




Within a few years, the chromosome myth was conclusively debunked. A 1970 
article in the Journal of the American Medical Association reported that, in vivo, “no 
difference was found in the rate of chromosomal aberrations before and after 
administration of LSD” (Pahnke et al. 1970, 1862). A year later, Science published a 
new meta-analysis on the subject, this time concluding that “pure LSD ingested in 
moderate dosages does not produce chromosome damage” (Siff 2015, 158). As an 
interesting aside, the US Army and CIA were already aware of this, having 
unsuccessfully attempted to replicate the chromosome studies. They made no effort, of 
course, to share these results with the scientific community (Lee and Shlain 2985, 154-
155)   
The media, which had so enthusiastically reported on the possibility that LSD 
caused genetic damage, paid little attention to the new finding that it did not (Goode and 
Ben-Yehuda 2009, 204; Pollan 2018, 209). “At the time,” Goode explains, “LSD 
pathology was news; non-pathology was not” (Goode 2008, 539). Not that it mattered—
by 1970, psychedelics were already criminalized. Concern over genetic damage played 
a significant role. In a 1967 FDA paper, broken chromosomes were one of the primary 
justifications for government control of LSD (Smith 1967, 13). At the precise time that 
criminalization was under consideration, the chromosome studies provided medical 
professionals and policymakers with further cause to suspect that psychedelics were 
dangerous. 
2: Professional Prejudice, Legal Obstacles, and Unsavory Associations 
Undoubtedly, the specters of psychosis and genetic damage gave medical 




many doctors, these concerns mainly served to confirm their preconceptions about the 
drugs. Psychedelics themselves, and the ways they were commonly used in therapy, 
were fundamentally incompatible with the paradigms of mid-twentieth century 
psychiatry. Their effects were unpredictable and difficult to test, a problem significantly 
compounded by legal barriers established by the FDA in the early 1960s. Moreover, the 
few effects that were consistent—hallucinations, ego dissolution, emotional volatility—
were considered symptoms of mental illness. The drugs’ dubious reputation was 
exacerbated by their association with maverick doctors and scientists, who ranged from 
unconventional to downright outlandish. Consequently, despite years of evidence 
suggesting that psychedelics were medically useful, most experts were unconvinced. 
One of the factors which made it difficult to accept the medical potential of 
psychedelics was their apparent unreliability. Although psychedelics were tested 
extensively in the 1950s, the results were frustratingly inconsistent. One study reported 
that when a hundred painters were dosed with LSD, all of them reported a boost to 
creativity. Yet, other studies claimed that LSD impaired mental functioning (Lee and 
Shlain 1985, 61-62). At the 1959 international conference on LSD, many participants 
reported success treating various mental illnesses with LSD. Others, such as the CIA-
affiliated chair Dr. Paul Hoch, saw no such improvements, and observed that “no 
patient asks for [LSD] again” (Lee and Shlain 1985, 69). At the 1967 NIMH 
Conference, one doctor exasperatedly remarked, “I doubt that we would find much, if 
anything, that we here can all agree upon concerning the LSD situation” (Meyer 1967, 
5). These discrepancies can be partially explained by the influence of setting and 




treated their patients with psychedelics, such as Dr. Humphrey Osmond, took pains to 
create a welcoming, relaxed environment, and made sure their patients knew what to 
expect before administering the drugs (Lee and Shlain 1985, 56-59).  
Not only did they appear vexingly inconsistent, but it was extremely difficult to 
design rigorous medical experiments with psychedelics. Although many patients 
reported phenomenal results from Dr. Osmond’s style of psychedelic therapy, 
mainstream psychiatrists were skeptical. Osmond’s method, and psychedelics in 
general, were not easily tested by double-blind experiment (Pollan 2018, 208; Richert 
2019, 83-84). Of course, researchers could try—there are several published studies on 
psychedelics from the 1960s which purport to be double-blind (Blacker et al. 1968, 342; 
Stevens 1987, 168-169). But generally, the intensity of the psychedelic experience made 
it quite clear who had received the real drug, especially with the high doses used by 
Osmond and his disciples. If a patient, an hour or so after ingestion, began experiencing 
vivid hallucinations, they could be reasonably sure they were not in the control group. 
The researchers, for their part, usually found it rather obvious which of their 
participants were given the real thing; most adults do not spontaneously exhibit visible 
ecstasy, awe, or terror after consuming sugar pills. 
The impracticality of testing psychedelics in the same manner as other 
experimental treatments became a major problem in 1962, with the new FDA 
restrictions on pharmaceutical testing. Any researcher or psychiatrist hoping to test 
experimental medication now required FDA approval (Belouin and Henningfield 2018, 
9). Since psychedelic experiments could not meet the “gold standard” of double-blind 




1966 that “LSD is having to bear the brunt of mushrooming controls while trying to 
prove itself” (319). As a result of these restrictions, say Lee and Shlain, “some of the 
most distinguished and experienced investigators were forced to abandon their work 
and the conditions that might have demonstrated LSD’s therapeutic potential virtually 
ceased to exist” (1985, 90-91). The medical community had to base their opinions off 
the limited research that had been done prior to 1962, most of which was not adequately 
controlled. 
These issues with testing protocols and regulations may seem pedantic, but their 
impact on the political process cannot be overstated. As will be discussed in the next 
subsection, the decision to criminalize psychedelics so severely was largely based in the 
psychiatric community’s reluctance to embrace them as medicine. This reluctance 
stemmed from an aversion to any substance that could not meet the standard of double-
blind testing. But, the barriers imposed by FDA regulation and the intrinsic nature of the 
drugs made it very difficult for psychedelics to meet that standard. It is not surprising, 
then, that most experts were skeptical of the near miraculous results claimed by 
psychedelic therapists. 
Not only were the effects of psychedelics inconsistent and difficult to test, but 
they were also commonly associated with mental illness. When psychedelics were first 
introduced to Western medicine, they were generally assumed to produce a “model 
psychosis” of sorts (see “Historical Background: The Peak”). Later research by Dr. 
Osmond and others demonstrated that psychedelic-induced hallucinations are quite 
different from those experienced in psychosis (Meyer 1967, 28). However, for many 




hallucination or atypical perception as pathological. (Lee and Shlain 1985, 68). Mogar’s 
1965 meta-analysis of psychedelic research describes “traditional scientific and cultural 
resistances to such phenomena as psuedo-hallucinations [sic], hypnogogic and dream 
images, extrasensory perception, and hypnosis . . . each of these . . . have traditionally 
been associated with the negative, bizarre, and abnormal” (149-150). Consequently, 
many psychiatrists found it absurd that psychedelics might successfully treat mental 
illness—how could they when they appeared to temporarily induce it? These 
perceptions also reinforced the concerns over psychosis. Since the effects of 
psychedelics at least superficially resembled psychosis, it seemed quite reasonable that 
a psychedelic experience could trigger a psychotic break. 
Even more problematic than the drugs themselves, however, were the 
researchers and therapists who advocated for them. Psychedelics were generally the 
domain of younger psychiatrists, recently graduated and eager to make a name for 
themselves with this radical new technique. These new therapists’ disregard for 
established psychiatric norms, accompanied by results that seemed too good to be true, 
invited suspicion (Stevens 1987, 176-178). Lee and Shlain (1985) argue that, like 
Galileo, the psychedelic therapists were condemned by the old guard for daring to 
challenge the dominant paradigm of their field. They were branded as eccentric and 
misguided, if not drug-addled charlatans (68).  The president of the American Medical 
Association scathingly remarked that “it was impossible to find an investigator willing 
to work with LSD-25 who was not himself an ‘addict’” (Lee and Shlain 1985, 91).  
The most influential upstart of all was Timothy Leary (see “Historical 




back only a few years, probably specifically to 1963 when Timothy Leary, a 
psychologist at Harvard and an apostle of LSD, was dropped from the faculty” (Walsh 
1966, 1729). As a national celebrity and impassioned advocate for the psychiatric, 
recreational, and spiritual use of psychedelics, Leary contributed more than anyone to 
their popularity among the American public (Belouin and Henningfield 2018, 9; Pollan 
2018, 185). However, he also contributed more than anyone to psychedelic research’s 
bad name. He shared the drugs freely with students, and often used them himself while 
conducting his research (Lee and Shlain 1985, 88). The “experiments” conducted by the 
Harvard Psilocybin Project ranged from psychedelic-fueled Bible readings to ancient 
Hindu “sex rituals” (Miles 2005, 68). After being dismissed, Leary venomously 
remarked that psychedelics were “more important than Harvard” (Lee and Shlain 1985, 
88). He donned white robes, dubbed himself the “High Priest” of LSD, and founded 
what amounted to a psychedelic party mansion in upstate New York (96-102). To most 
outside observers, it appeared that psychedelics had reduced a formerly respectable 
Harvard professor to a spiritual, hedonistic quack. 
Thanks to the antics of overenthusiastic evangelists like Tim Leary, psychedelic 
research took on a veneer of mysticism and subjectivity. This perception was magnified 
by the difficulty of gathering high quality data on psychedelics, as well as their inherent 
unpredictability. It is therefore understandable why many doctors believed that “the 
words LSD and scientific objectivity are mutually exclusive,” as one commented in 
1967 (Meyer 1967, 5). All the research that had supported medical psychedelic use was 
now suspect. Pollan laments that “in the mid-1960s, an entire body of knowledge was 




experience had never happened” (2018, 142). Psychedelics now seemed too risky and 
unreliable for most psychiatrists to recommend their medical use. Then, just as the 
federal government began to debate criminalization, new research emerged suggesting 
that psychedelics could cause genetic damage. This confluence of factors ensured that, 
at the crucial moment when they were being asked to testify, very few experts were 
comfortable vouching for psychedelics’ medical potential. In the next subsection, it will 
become clear that this chilliness from the medical community was the decisive element 
in the criminalization of psychedelics. 
 
B: The Anti-Drug Moral Framework 
Up to this point, this paper has covered a broad range of historical processes that 
contributed to the criminalization of psychedelics. The literature review explored the 
pattern of expanding drug criminalization in the US. Then, the Moral Panic section 
observed that there was indeed a moral panic about psychedelics, but it was not the 
cause of criminalization. Up to this point, this section has focused on how the American 
psychiatric community came to believe that psychedelics were not medically useful. All 
these factors must now be considered together. 
The history of drug policy in the US suggests a moral framework, shared 
between many Americans, in which recreational drug use is considered not only unwise, 
but evil. This belief is justified by a range of socially constructed stereotypes about 
drugs and drug users—Fish writes that “the field of drug prohibition is rife with reified 
concepts that have led to untold mischief” (1998b, 16). This underlying moral current 




sometimes engineered by politicians for electoral advantage. It also ensures that, panic 
or not, the government’s default response to the emergence of new recreational drugs is 
to criminalize them. The objective risks associated with the drug are irrelevant—the 
degree of criminalization is determined not by danger, but by medical potential. 
Consequently, in the mid-1960s, when most experts seemed to agree that psychedelics 
had no medical potential, US lawmakers took that as sufficient justification to 
criminalize them at the highest level. 
1: Protestant Influences: Drug Takers Portrayed as Deviants 
The early 20th century saw a turning point in American cultural understandings 
of drug use (“Literature Review: Drugs in the United States”). Thanks to the efforts of a 
handful of influential, dedicated “moral crusaders,” public opinion began to condemn 
intoxication of any sort. The biggest success of this movement was Prohibition in the 
1920s—although that victory was short-lived, since alcohol was simply too popular to 
permanently outlaw (Levine and Reinarman 1998, 260-261, 268). Other substances, 
however, were much more easily demonized by moral crusaders; recall how Narcotics 
Bureau Chief Harry Anslinger managed to turn the American public against cannabis. A 
similar aura of fear and danger surrounds all new recreational drugs. Vatz and Weinberg 
note that Americans tend to incorrectly assume that all recreational drugs are highly 
dangerous (1998, 65-66). This has created a pattern of drug-related moral panics in the 
US: opium, alcohol, and cocaine in the 1900s; cannabis in the 1930s; psychedelics in 
the 1960s; crack in the 1980s, etc. (Goode and Ben-Yehuda 2009, 198). It seems a new 
substance cannot emerge in America without being subjected to moral panic and 




symptoms of a broader, more constant cultural disposition against consciousness 
alteration. 
The origins of the anti-drug moral framework are multi-faceted. As discussed in 
the literature review, scholars like Morgan (1981) argue that anti-drug attitudes 
originated in response to the prevalence of alcohol and opium use around the turn of the 
century. Alcohol and opium are addictive, sedating, and disinhibitory. For the American 
public, it seemed reasonable to assume that other, more unfamiliar drugs, such as 
cannabis, would have similar effects (62-63). However, this does not explain the origins 
of the moral crusaders who led the charge. 
Ultimately, the early 20th century anti-drug campaigns were a product of 
American Protestant culture. In a previous paper, I explore this connection extensively 
(Sproul 2019). I compare the case of the US, a predominately Protestant nation with 
harsh drug laws, with Portugal, a predominately Catholic one that has decriminalized 
drug use nationwide. Although the two countries share a similar history of drug 
epidemics, Protestant moral activism, I argue, made all the difference (11-13). 
Protestants are much more inclined than Catholics to pursue organized “temperance 
movements” to outlaw intoxicants. In fact, previous research by Harry Levine shows 
that, of the European nations to undergo major temperance movements, all have been 
predominately Protestant (1993, 2). The brand of Protestantism that pervaded late 19th 
century America was particularly disposed to moral crusading. L. A. Schmidt describes 
the emergence around that time of “a new theology focused on religious salvation 
through the suppression of vice. This new religious ideology provided a core of beliefs 




1). In his Hellfire Nation, James Morone links this neo-Puritan creed to nearly every 
facet of American political life. “Visions of vice and virtue define the American 
community,” he says (2003, 5). Consequently, more so even than other Protestant 
nations, American history is pervaded by mass social movements to combat sin (10-12). 
For these Puritan crusaders, intoxication of any sort was a social disease to be 
eradicated. Levine explains, “Protestantism produced a psychology which stressed the 
importance of self-regulation and self-restraint” (1993, 9). Since drug use intervenes 
with one’s capacity for self-control, Puritans considered it morally intolerable (Morone 
2003, 16). As noted by both Morgan and my own research, the rhetoric used by anti-
drug moral crusaders was pervaded by references to “free will” (Morgan 1981, 50; 
Sproul 2019, 11-12). In one of his infamous anti-cannabis tirades before Congress, 
Harry Anslinger (1937) asserted that “qualities of the drug render it highly dangerous to 
the mind and body upon which it operates to destroy the will.” As will be seen in the 
next subsection, the same exact stereotypes were extended to psychedelic users in the 
1960s. 
These perceptions tend to catalyze moral panics when a new drug or pattern of 
drug use is revealed to the public. However, the anti-drug moral framework also ensures 
that all new psychoactive substances without apparent medical potential are met by the 
government with demonization and criminalization—independently of whether a moral 
panic is occurring. In the 1930s, for example, despite the best efforts of anti-drug 
proselytizers like Harry Anslinger, no major moral panic over cannabis emerged among 
the general public. Nevertheless, despite the lack of public concern or widespread use of 




Ben-Yehuda 2009, 198). The American cycle of drug-related moral panics is related to, 
but not the cause of, its cycle of expanding criminalization. 
The framing of drug users as deviant and deserving of punishment informs not 
only US policy, but international law. As discussed previously, the US has been the 
primary architect of the international drug criminalization regime (see “Literature 
Review: Drugs in the United States”). Andreas and Nadelmann recount how “the 
United States has advocated for the imposition of punitive control systems in all 
countries . . .US drug enforcement officials have persistently criticized foreign 
governments . . .for their emphasis on public health approaches to the drug problem” 
(2006, 43). Moreover, Emily Crick (2012) argues that moralizing anti-drug rhetoric has 
spread from American political discourse to the world at large. Through international 
agreements like the 1961 Single Convention on Narcotic Drugs, she says, the “global 
‘Self’” was “constructed as being morally good in contrast to the ‘evil’ of narcotic drugs 
. . . no other international convention describes the activity it seeks to prevent in such 
terms” (408). Of course, say Andreas and Nadelmann, other nations were already 
sympathetic to these views—if they were not, US efforts to export its drug policy and 
discourse would have failed as miserably as its attempt to globalize alcohol prohibition 
(2006, 43). Nevertheless, America’s Puritan anti-drug moral framework provided the 
theoretical grounding for the international prohibition regime.   
Of course, that is not to say that drug criminalization, wherever it occurs, is 
always the result of Puritan crusading. Many of the countries with the most draconian 
drug laws, such as China, North Korea, and Iran, are largely outside the American 




for drug possession and trafficking, up to and including execution, are likely the result 
of domestic politics. For example, the severe criminalization of drugs in Muslim nations 
like Iran and Saudi Arabia, and the United Arab Emirates was likely driven by a similar 
anti-drug moral framework to that in the US, but based in Islam rather than Puritanism. 
Although a detailed analysis of drug policy in the Islamic world is outside the scope of 
this thesis, interested readers should look to Mansur Ali’s (2014) essay on the subject. 
As for southeast Asia, the RAND corporation has produced a thorough report on drug 
policy in the region, which would be an excellent starting point for further research 
(Pardo, Kilmer, and Huang 2019). In any case, though some countries may treat their 
drug users even more harshly than the US, it was Americans who orchestrated the 
criminalization of drugs throughout most of the Western world. Puritanism is not the 
only cause of drug criminalization, but in the US and in international law, it has been a 
crucial driving factor.  
Under the anti-drug moral framework, which views all drug use as equally 
unacceptable, the objective risks associated with a particular drug are largely irrelevant. 
If a drug has no medical use, it is criminalized to the highest degree. Note the way that 
drugs are divided by the 1970 Controlled Substances Act. Schedule I, the most highly 
criminalized category, is distinguished from lower scheduled not by extreme danger, or 
addiction potential, but by “no currently accepted medical use in the United States” 
(DEA n.d.). Of course, drugs in this schedule are supposed to also have a “high 
potential for abuse,” but if a drug’s “potential for abuse” does not correspond to its 




admits that “the term ‘potential for abuse’ is not defined in the [Controlled Substances 
Act]” (DEA 2017).  
In practice, the drugs in Schedule I are often far safer and less addictive than 
those in lower schedules. Cannabis and psychedelics are in Schedule I, whereas 
morphine, methamphetamine, and cocaine are in the less severe Schedule II, and highly 
addictive benzodiazepine tranquilizers like Xanax are all the way down in Schedule IV 
(DEA n.d.). To compound the problem, once a drug has been condemned as medically 
useless and placed in Schedule I, it becomes almost impossible to redeem. David Nutt, a 
contemporary drug researcher, bemoans the “regulatory jungle” that anyone hoping to 
study Schedule I drugs must navigate. “Limitation to clinical research produced by the 
regulations almost certainly has done much more harm than good to society by 
impeding medical progress” (2015, 5). No matter how safe a drug may be, if it appears 
to lack medical applications, it will be banned, and that ban will make it nearly 
impossible to conduct further medical research, perpetuating a vicious cycle of 
unfounded fear. 
This was the dominant paradigm of drug policy in the US around the time that 
psychedelics became popular for recreational use. In 1966, in a scathing critique of the 
FDA crackdown on psychedelics, Rosborough effectively summed up the popular view: 
“society has not accepted the use of drugs for pleasure. To experience synthetic 
emotions is believed to be immoral” (324). This view resulted from the efforts of 
Protestant moral crusaders in the early 20th century. These activists established the 
notion, both at home and abroad, that the non-medical use of psychoactive drugs was 




each substance were hardly relevant—all non-medical drug use was considered deviant 
and worthy of punishment. By examining government discourse on psychedelics in the 
late 1960s, one can see how the anti-drug moral framework impacted the national 
discussion and led to the criminalization of these substances. 
2: The Anti-Drug Moral Framework and Psychedelics 
As discussed in the previous section, by the mid-1960s, most reputable 
psychiatrists had concluded that psychedelics lacked clear medical potential. So, when 
the time came to consider the criminalization of psychedelics, scientists were reluctant 
to give the drugs their full-throated endorsement. Under the anti-drug moral framework, 
an apparent lack of medical use was sufficient cause to criminalize psychedelics at the 
highest level. 
In the public discourse about psychedelics, the Protestant concern with self-
regulation and productivity was on full display. A 1966 article in the Catholic 
Transcript, decrying Tim Leary’s “LSD cult,” asserts that psychedelics could not 
possibly be used for good since “no personal and responsible act can be performed 
when . . . the intellect and free will are deliberately frustrated” (The Catholic Transcript 
1966).  Indeed, the common thread linking the various horror stories about psychedelics 
was the fear that users would be unable to refrain from self-destructive, violent, and/or 
criminal behavior. TV Star Art Linkletter famously attributed his 20-year-old 
daughter’s suicide to an LSD-induced panic, and other reports of psychedelic-addled 
youngsters inadvertently throwing themselves out of windows or off roofs were quite 
common (Torgerson 1969; Dreyfuss 1967; Gordon 1963, 40; NYT 1971). The papers 




staring at the sun under the influence of LSD—stories which later turned out to be 
entirely fabricated (Siff 2015, 154-155).  
The national news also blamed psychedelics for innumerable murders, sexual 
assaults, and other acts of violence (see “Was There a Moral Panic?”) (NYT 1966). 
However, these reports are dubious: they were based on anonymous sources and often 
had clear inconsistencies (Stevens 1987, 277). Additionally, police testifying before 
Congress were unable to provide any concrete examples of violent crimes attributable to 
psychedelics (275-276). Contemporary research suggests that, if anything, psychedelic 
use reduces criminality and violent inclinations (Hendricks 2014; Hendricks 2017; 
Thiessen et al. 2018). The stories are, however, highly reminiscent of the rhetoric used 
by Harry Anslinger in the 1930s about cannabis users: “some people will fly into a 
delirious rage, and they are temporarily irresponsible and may commit violent crimes” 
(Anslinger 1937; Stevens 1987, 276-277). Stevens comments that “if you changed a few 
nouns in any of the antimarijuana stories of the Thirties, you ended up with a reasonable 
facsimile of the standard ‘LSD madness’ story” (1987, 277). The panic that emerged 
surrounding psychedelics in the late 1960s was not an isolated occurrence, but rather 
was symptomatic of the same moral framework that drove the criminalization of 
cannabis. Indeed, this framework ensures that nearly all new drugs, deservedly or not, 
are associated with crime and violence in the public and government eye (for further 
discussion, see “Disproportionate Reaction”).  
Another core element of the anti-drug moral framework is the fear that drug use 
inhibits productivity (Siff 2015, 177). Morgan observes that throughout the 20th century, 




“medical” use of the same substances to promote productivity (1981, 158). For 
example, amphetamines are illegal for adults to use recreationally, but totally acceptable 
to administer to young children who struggle to focus in class (in the form of 
prescription drugs like Adderall). Morgan theorizes that the stereotype of the lazy drug 
user emerged in the early 20th century, due to perceptions of opium users as lethargic 
and unmotivated (50). Since then, he says, it has been applied to all recreational drug 
users.  
Indeed, one of the most common worries about psychedelics was that they 
would turn their users into shiftless deadbeats. According to Life magazine, psychedelic 
users often “discover that life is only a game, then begin playing it with less and less 
skill. Their vision becomes a beguiling scrim drawn over a life of deepening failure” 
(Life 1966). The article provides no statistics, research, or even anecdotes to support 
this claim. Another article from the New York Times asserted that “Of all of LSD’s 
effects, the worst may be . . . permanent dulling of users’ objective judgement and its 
replacement by purely subjective values” (Hill 1967). This allegation is so vague as to 
be ludicrous—how exactly is “objective judgement” measured? With both articles, the 
reader is meant to take it as self-evident that recreational drug use (of any sort) erodes 
the will. 
All these stereotypes about drug users were at least in part derived from—and 
inextricably connected to—racial and cultural bias. Throughout US history, discourse 
about drug laws has been couched in racial language, and the laws themselves have 
been weaponized against marginalized racial populations (see “Literature Review: 




drug debate . . . The identification of many drugs, especially the hallucinogens . . . with 
mystical eastern religions reawakened the old stereotypes of passivity and weakness 
long associated with those cultures” (1981, 165). This association was not merely 
subconscious. Opponents of Tim Leary’s Harvard Psilocybin Project often drew 
derogatory connections to the history of hallucinogenic drug use in India, which one 
critic called “one of the sickest social orders ever created” (Stevens 1987, 160, 199).  
One of the media’s biggest concerns about psychedelics was the direct threat 
they posed to Puritan values. Communities devoted to psychedelic experimentation 
were frequently and disparagingly referred to by journalists as “cults” (Abramson 1966; 
Gordon 1963; The Catholic Transcript 1966). The New York Times flatly stated in 1967 
that “LSD is a threat to aspects of traditional religion” (Fiski 1967). Some even argued 
that the inherent evil of drug use outweighed any medical benefits psychedelics might 
possess. One doctor wrote for the LA Times that, even if LSD can effectively treat 
alcoholism, “by giving man by drugs what he ought to earn through moral efforts, we 
may have committed . . . sin against the meaning of his earthly existence” (Winkler 
1960).  
 These worries emerged because, even more than other drugs, psychedelics 
appeared fundamentally incompatible with the American Christian tradition. As was 
shown in the 1962 “Miracle of Marsh Chapel” (see “Historical Background: The 
Peak”), psychedelics could reliably induce mystical, even spiritual experiences (Lee and 
Shlain 1985, 76-77). For proponents of psychedelic use, like Aldous Huxley, and Tim 
Leary, this was the main objective. If there was any doubt that psychedelics posed a 




“League for Spiritual Discovery” (abbreviated, of course, “LSD”). The league was a 
religious organization devoted to the exploration of inner spirituality through 
psychedelics. They propounded Eastern mysticism, particularly the Tibetan Book of the 
Dead, as a complement and guide to the psychedelic experience (Lee and Shlain 1985, 
105-110). Leary’s psychedelic religion was far from the only one—in fact, by the end of 
1966, there were two other, separate religious organizations (the Neo-American Church 
and the Adanda Yogic Ashram) headquartered in Leary’s own house (Miles 2005, 228). 
Something about the psychedelic experience tended to persuade users that they had 
undergone genuine spiritual revelation.  
The moral backlash to these psychedelic proselytizers was inevitable. Stevens 
observes that, “to discover, in the recesses of the mind, something that felt a lot like 
God, was not a situation that . . . organized religion wished to contemplate” (1987, 180). 
Indeed, the most common reaction to claims of psychedelic-induced enlightenment was 
outrage and dismissal. In a 1966 article, the Catholic Transcript asserts that “despair is 
a logical corollary of dependence on a drug like LSD for religious experience.” But 
despite the horror of mainstream religious leaders, the late 1960s saw more and more 
young people turning up their noses at Christian tradition in favor of drug-fueled 
ecstasy. 
In light of these developments, it is not at all surprising that a moral panic 
emerged around psychedelics. Due to the dominant Puritan culture, Americans were 
already predisposed against recreational drug use of any sort. Drugs were presumed to 
be highly dangerous, and to cause criminal behavior and unproductivity; psychedelics 




even more concerning than other drugs. In the eyes of neo-Puritans, psychedelics were 
not just intoxicants, but false idols. 
3. The Anti-Drug Moral Framework and the US Federal Government 
Of course, it was not the media nor the public who criminalized psychedelics. 
The anti-drug moral framework was similarly entrenched in the minds of policymakers. 
At the 1966 Senate Hearings, most Senators considered criminalization the default 
position. Indeed, notes Stephen Siff, “deliberation ranged only from control to 
prohibition, not the full gamut to inaction or further liberalization” (2015, 176). 
Additionally, most Senators leaned heavily toward the prohibition side of the spectrum. 
“The burden of proof,” said Senator Jacob Javits (R – NY), “is on the scientists and the 
government departments which contend against individual prohibition” (NIH 1966, 8).  
One such scientist was Dr. Yolles of the NIMH, who made it quite clear that 
psychedelics were not especially addictive or dangerous. “Psychological dependence on 
drugs of the LSD type . . . is usually not intense,” he says, and “the number of adverse 
reactions . . . is in the same range of magnitude of occurrence as in any other type of 
psychiatric treatment” (NIH 1966, 22, 24). However, he admitted that the jury was still 
out on the drugs’ medical potential (26). For Senator Ribicoff, this alone was sufficient 
reason to criminalize. The chief question he had for Dr. Yolles was, “Why should not 
[psychedelic] possession be prohibited? . . . What about heroin and similar narcotics? 
You think that we should prohibit their possession, don’t you?” (NIH 1966, 33). For 
Ribicoff and his colleagues, it was irrelevant that psychedelics had completely different 
safety and addiction profiles than heroin—both were drugs without medical potential, 




To be clear, the scientists and doctors generally did not recommend the 
criminalization of psychedelics, or any drugs for that matter. At the 1966 Senate 
hearings, Dr. Yolles was vocally opposed to fully criminalizing LSD: “If we make the 
possession of LSD illegal, it will drive it further underground and make what is perhaps 
the beginning of flaunting of authority . . . a more pathological process and a more 
strongly accented act of rebellion” (NIH 1966, 32). At the 1968 FDA hearings on 
psychedelics, the medical professionals who testified were almost unanimously “of the 
opinion that making the possession of dangerous drugs a crime would be ineffectual as 
a deterrent to their use” (Burnett 1969, 638).  
This reflects a broader pattern within the history of American drug policy; since 
the early 20th century, medical professionals have resisted efforts to criminalize drug 
use. Morgan describes how a massive drug control bill was defeated in 1910 by the 
advocacy of medical professionals (1981, 107). The medical establishment also sharply 
criticized the 1915 Harrison Act, which Massing (1998, 86) calls the “legal foundation 
of drug prohibition in the United States.” (Morgan 1981, 116). However, by the 1930s 
the law-enforcement approach was entrenched, and medical experts’ calls to treat drug 
abuse as a medical issue went unheard (134-135). So it went with psychedelics. As 
researchers like Dr. Sidney Cohen attempted to balance the medical promise of 
psychedelics with an appropriate degree of caution, policymakers exercised selective 
hearing (Pollan 2018, 210-211). The prevailing expert opinion was: these drugs have 
potential but are unproven and possibly risky—we should approach them with caution. 




This was the message that the FDA took away from its hearings on the subject, 
and the message that they shared with lawmakers in a remarkable 1967 report titled 
“LSD: The False Illusion” (Smith 1967). As the FDA was tasked with enforcing 
regulations on psychedelics before criminalization, they were the chief government 
authority on the subject and their opinion held great sway. Indeed, FDA Commissioner 
James Goddard was one of the most important advocates for the criminalization of 
psychedelics, calling LSD “one of the most dangerous drugs with which I am 
acquainted” (NYT 1968). In their report, the FDA echoes the concerns of medical 
professionals over the safety of psychedelics, while largely ignoring the same 
professionals’ opposition to criminalization (Smith 1967, 13-15). Indeed, the report 
tends to overstate the risks of psychedelics, even relative to the worries of psychiatrists 
at the time. For example, although experts largely agreed that it was a small minority of 
LSD users who experienced adverse effects (see previous section - Safety Concerns), 
the FDA asserted that “most ‘triers’ and users go through intensely frightening and 
terrifying experiences under the drug” (13).  
Even more striking than their inflation of the dangers, however, was the FDA’s 
explicit endorsement of the anti-drug moral framework. The very first page of the report 
asserts that any civilization which incorporates drugs into recreation or spiritual practice 
is “primitive.” The author opines, “In more sophisticated societies drugs have served 
more limited goals—those of treatment and prevention of disease” (Smith 1967, 10). 
Here, the attitudes of racial and cultural supremacy that inform the anti-drug moral 
framework are on full display. The report also evokes Fish’s observation that, in the 




report on LSD shows that this attitude is not merely a cultural norm, but the official 
position of the US government.  
The report proceeds to bring a series of allegations against recreational 
psychedelic users. Hippies have a “pharmacocentric ideology,” the author says, with 
these core tenants: “stimulate the senses as much as possible, change the internal world 
with drugs, and ignore constructive actions to improve the external world” (Smith 1967, 
14). He goes on to assert that “personality patterns of people who ingest LSD indicate 
strongly that they are less able to postpone pleasure and to withstand the frustrations of 
everyday life” (14). The FDA cites no source—in fact, the research that had been done 
at the time on frequent LSD users suggested just the opposite (Mogar and Savage 
1966). However, the claim quite vividly demonstrates the anti-drug moral framework in 
action. It is taken as a given that recreational drug use of any kind must destroy self-
control (one of the main tenants of the anti-drug framework). 
Later in the report, the author makes a truly remarkable claim: “Even more 
serious and prevalent than . . . negative reactions are the adverse consequences of so-
called ‘positive trips’ which lead the user to feel that he has found the answers to life's 
problems . . . he only too often winds up disengaging himself from productive, focused 
personal and social activities” (Smith 1967, 15). First, note the implicit message: 
individual well-being and happiness are less important than productivity. This quote 
also reaffirms the unfounded notion that psychedelic drug use inhibits productivity. No 
evidence for this claim is needed; under the anti-drug moral framework, it is a given 




With these beliefs in mind, Congress’s 1968 vote to criminalize psychedelics is 
perfectly comprehensible. The federal government’s position was that any drug without 
undoubted medical potential ought to be criminalized, since drug users would inevitably 
be driven to listlessness, if not violence. Since experts were not willing to vouch for 
psychedelics’ medical potential, and recreational use was accelerating, federal 
lawmakers chose to address the issue the same way they had addressed drug problems 
since the turn of the century—severe criminalization. 
Does that mean that psychedelics would have remained legal if more experts had 
been willing to vouch for their safety and medical efficacy? Probably not—the anti-drug 
moral framework would have guaranteed criminalization sooner or later, as it has for 
nearly every other intoxicating substance (tobacco and caffeine notwithstanding). 
However, the severity of psychedelic criminalization is directly attributable to the 
perceived lack of medical benefits. As evidence, look to amphetamines, which were 
extremely popular in the 1960s for recreational use, and are more dangerous and 
addictive than psychedelics by every measure. Amphetamines were criminalized as 
well, around the same time as psychedelics, but the penalties for illicit amphetamine 
possession or sale were far less stringent (Bayer 1989, 24). Criminalization itself was 
most directly due to the anti-drug moral framework, but the degree of criminalization 
was a result of psychedelics’ abandonment by the psychiatric community. 
4. Drug Hysteria, Partisan Politics, and the 1968 Election 
Of course, the timing of the decision was not entirely coincidental. As is 
discussed in the Moral Panic section, the federal push to criminalize psychedelics 




the moral panic was in full swing. Capitalizing on this anxiety, the Nixon campaign 
highlighted drug abuse as one of the nation’s most pressing issues (Lee and Shlain 
1985, 221; Massing 1998, 97 ; Siff 2015, 184-185). When Congress voted on the 
question of LSD criminalization, each legislator must have been acutely aware that a 
presidential election was just over the horizon, and that their voting record on drug 
legislation would be thoroughly scrutinized. 
With drugs so prominent in the public eye, voting against the criminalization of 
psychedelics would be a risky move. Due to the anti-drug moral framework, American 
politicians on either side of the aisle who dare to speak out against prohibitionist 
policies are branded “soft on drugs” (Fish 1998a, 2). Especially with a moral panic in 
full swing, voting for criminalization was the politically expedient choice, independent 
of the lawmakers’ own beliefs. Of course, their beliefs mattered; Morgan observes that 
drug prohibition is almost never due to electoral incentives alone (1981, ix). But, in 
addition to the genuine moral outrage that government officials felt about recreational 
drug use, the 1968 election provided a compelling reason to vote “yes” on 
criminalization. 
It is important to note that, though the election undoubtedly played a role, 
banning psychedelics was not a partisan issue. Of course, Nixon and his supporters 
were Republicans, but most Democrats were similarly loath to tolerate recreational drug 
use. In 1965, the Drug Abuse Control Amendments (DACA), which banned the 
unauthorized sale and manufacture of psychedelics, passed Congress unanimously 
(GovTrack n.d. a). Then, in 1968, the amendment to DACA that criminalized personal 




(GovTrack n.d. b). Finally, in 1970 Controlled Substance Act, which placed 
psychedelics in the strictest possible enforcement category, passed in the House by a 
vote of 341-6. In the Senate, there was not a single “no” vote (GovTrack n.d. c). These 
nearly uncontested votes imply that, in the late 1960s, the anti-drug moral framework 
dominated the minds of voters and politicians so thoroughly that opposing 
criminalization was unthinkable, regardless of party affiliation. 
5. Exporting Morality 
One question remains—how does this theory square with the 1971 UN 
Convention on Psychotropic Substances? As discussed in the Methods Section, the 
domestic politics of other UN member nations are outside the scope of this analysis. 
Since this paper has already established that the US was not the primary driver of 
psychedelics’ inclusion in the Convention, it can only speculate as to the cause. There is 
evidence, however, to suggest that the anti-drug moral framework extends to the 
international sphere.  
The 1971 Convention, like US drug policy, looks to medical potential before 
considering objective risk. In fact, notes an eyewitness account of the Convention, the 
degree to which a drug was criminalized in 1971 was almost exclusively determined by 
medical potential. The Convention, he says, “consists of two treaties: one for ‘street 
drug’ hallucinogens in Schedule I and one for pharmaceuticals in Schedule II, III and 
IV. There are extremely strict control measures for Schedule I substances and very 
weak ones for Schedule II and III substances and nothing for Schedule IV” (Bayer 
1989, 24). These pharmaceuticals, namely amphetamines and tranquilizers, have well-




psychedelics (Nutt and Phillips, 2010, 1591). This implies that scheduling decisions 
were based almost exclusively on medical utility, with little attention paid to other 
characteristics.  
To explain how American morals might have shaped international drug law, 
O’Manique invokes a phenomenon called “international norm diffusion” (2014, 5). The 
US’s outsize role in shaping the international drug criminalization regime, she argues, 
may have functionally exported its anti-drug moral framework to other nations. A 
fruitful avenue for future research would be to evaluate this claim, perhaps by looking 
to the domestic politics of other countries who advocated for psychedelic 




VI: Conclusion and Discussion 
The preceding pages examine an odd phenomenon in American politics. In the 
1950s, psychedelics seemed set to revolutionize mental healthcare. A relatively safe 
class of substances with extraordinary results in early experiments, psychedelics could 
have joined anti-psychotics and tranquilizers in the core psychiatric toolkit. Instead, in 
1968, the US federal government voted to criminalize the personal possession of 
psychedelics and prohibit their medical use entirely. How can this series of events be 
explained? 
To answer this question, this thesis used a qualitative process-tracing method, 
detailed in the Methods section. By collecting and synthesizing a range of secondary 
and primary sources, a historical timeline was constructed. This timeline (see Historical 
Background) traces the rise and fall of psychedelic use in the US, beginning with the 
military-intelligence community’s secret experiments with LSD in the 1950s. It 
describes how psychedelics grew into a cultural phenomenon in the early 1960s and the 
connection between psychedelic drugs and the “hippie” counterculture. Finally, it 
details the federal government’s meandering path toward criminalization, beginning 
with new FDA regulations in 1962 and culminating with psychedelics’ inclusion in 
Schedule I of the US’s Controlled Substances Act of 1970 and the UN Convention on 
Psychotropic Substances in 1971. 
Next, in the literature review, the secondary literature on drug policy and 
psychedelic criminalization was explored. Many independent sources agreed that the 
US has exhibited a pattern of expanding drug criminalization over the past century, 




in the ongoing “War on Drugs.” As for the criminalization of psychedelics specifically, 
most scholars invoke the concept of “moral panic” to explain the rapid policy transition. 
In the mid-1960s, the argument goes, there was a sudden explosion of media attention 
paid to psychedelics, almost entirely negative. The media rushed to capitalize on public 
concerns by publishing uncorroborated stories of psychedelic users who had died, gone 
insane, or committed heinous acts under the influence. The resulting wave of public 
hysteria forced the government’s hand, and they criminalized psychedelics to soothe the 
fears of the masses (Goode and Ben-Yehuda 2009). There are variations on the moral 
panic hypothesis, such as DiPaolo’s (2018) theory that the moral panic was deliberately 
engineered by the government in order to criminalize the hippie community. However, 
most scholars accept the core argument that negative media representations and public 
hysteria were the primary causes of psychedelic criminalization. 
The Moral Panic section of this thesis evaluated the moral panic argument 
against the historical record. There was substantial evidence to support the first half of 
the story—there was undoubtably a surge of negative media portrayals of psychedelics 
in the mid to late 1960s. Additionally, moral panic theory offers many other helpful 
explanatory tools. For example, the concept of “folk devils” helps explain why hippies 
and other psychedelic users faced such excessive persecution and demonization. 
Particularly, the notion of “spurious attribution” helps explain why psychedelic users 
were so frequently cast as violent or prone to crime, despite clear evidence to the 
contrary (Cohen 1972, 54-55). 
However, although moral panic theory helps to explain many of the events that 




why the drugs were criminalized. Most obviously, the FDA had already been tightening 
controls on psychedelic research for years, and the Senate had already conducted its 
1966 hearings on LSD criminalization, before the moral panic ever began. Moreover, 
government actors approached criminalization slowly, deliberately, and with extensive 
input from independent experts. This does not align with the knee-jerk governance that 
tends to follow a moral panic (Cohen 1972, 133-138). Finally, the moral panic theory is 
entirely unable to explain the global criminalization of psychedelics. The US was not 
one of the primary advocates for psychedelics’ inclusion in the 1971 Convention on 
Psychotropic Drugs, so American politics could not have possibly caused that outcome. 
To reconcile the strengths of moral panic theory with its weaknesses, the Alternative 
Theory section of this thesis provides a more nuanced account of psychedelic 
criminalization. 
That section argues that, due to the American Protestant culture and the 
popularity of opium, the turn of the century saw a moral crusade against intoxication of 
all kinds. This crusade resulted not only in Prohibition, but in a set of cultural 
stereotypes and moral convictions surrounding drug use. Since then, most federal 
lawmakers, as well as their constituents, have believed that recreational drug use 
invariably saps the user’s productivity and self-control, promoting crime and violence. 
As such, the only appropriate response to any novel psychoactive substance without 
medical potential was severe criminalization. 
It was with these beliefs in mind that federal legislators considered 
criminalization in the late 1960s. At the time, psychedelics were relatively untested, 




conventional assumptions. Additionally, psychedelics’ reputation was tarnished by their 
use as an instrument of torture by US military intelligence agencies, and by their 
association with controversial public figures like Tim Leary. Therefore, few reputable 
medical professionals were willing to endorse them as a medicine during the 1966 
Senate hearings and other contemporaneous investigations. Although those same 
experts advocated against criminalization, for lawmakers and laypeople it appeared to 
be the natural option. As for the international decision to criminalize psychedelics in 
1971, this may be at least in part the result of American influence on global culture and 
moral beliefs. However, there are likely many other contributing factors, such as the 
domestic politics and culture of other UN member states, that play a role as well. So, 
although criminalization in the US is explained well by this theory, further research will 
be necessary to explain global criminalization. 
This thesis is heavily indebted to prior investigations. The majority of the 
historical information included here has already been reported in much more extensive 
detail by Lee and Shlain’s Acid Dreams, Siff’s Acid Hype, Stevens’s Storming Heaven, 
and Pollan’s How to Change Your Mind, among others. This paper builds upon the 
foundation of these well-researched accounts and checked them against each other, 
other secondary sources, and the available primary source evidence. It is through this 
process that the account of historical events described in this thesis was developed. 
This study is also far from the first to describe the anti-drug moral framework in 
the US. Most notable, perhaps, is Morgan’s 1981 work Drugs in America, an in-depth 
examination of the history and culture surrounding US drug policy. Additionally, in 




considerable attention to the popular notion of drugs as invariably dangerous and a 
major cause of crime (1998, 64-66). This thesis expands on these analyses and 
integrates them with other literature documenting the history of drug-related moral 
panics in the US, such as Goode and Ben-Yehuda’s 2009 work on the subject. 
Moral panics, this paper argues, emerge occasionally as a direct result of the 
anti-drug moral framework. However, criminalization of drugs is not always a result of 
moral panics—the anti-drug moral framework ensures that, when new psychoactive 
substances emerge, lawmakers tend to see criminalization as a default option, regardless 
of whether the public is highly concerned. This aligns neatly with Hawdon’s (1998) 
analysis of the state’s role in generating moral panics. Rather than merely translating 
public opinion into law, he writes, “state initiatives regarding drugs often precede public 
opinion and create concern independently of the objective extent or seriousness of the 
problem” (420). Evidently, in the case of psychedelics, this is precisely what occurred. 
In the literature review, significant attention was paid to the scholarly debate 
between Goode and Ben-Yehuda, the most impassioned advocates of the moral panic 
theory of psychedelic criminalization, and Cornwell and Linders, its most severe critics 
(see “Literature Review”). The theory developed in this paper suggests that both sides 
have merit, but Cornwell and Linders are more successful at explaining psychedelic 
criminalization. Goode and Ben-Yehuda quite persuasively argue that the response to 
psychedelics in the late 1960s was entirely disproportionate to their actual harms (2009, 
202-205). But without disputing that point, Cornwell and Linders correctly observe that 
the moral panic theory fails to explain the cautious, deliberative manner in which 




Cornwell and Linders’s alternative theory—that “prohibition emerged from a 
process of deliberation, communication, and debate among various segments of the 
public as well as members of the legislative bodies”—is fundamentally sound (2002, 
326). However, they are overly critical of moral panic theory. Although they are correct 
that a moral panic alone is insufficient to explain psychedelic prohibition, moral panic 
theory provides a variety of useful analogies and analytical tools (see the discussion of 
folk devils and spurious attribution above). A general defense of moral panic theory is 
beyond the scope of this paper. However, one is inclined to agree with Goode that, 
although it may not perfectly explain every instance of deviantization, “The moral panic 
notion continues to illuminate social processes and deserves to remain in the 
sociologist’s conceptual tool-box” (Goode 2008, 533). 
One final point bears consideration: today, the winds seem to be changing for 
psychedelics once again. In the 21st century, there has been a major revival of medical 
research into psychedelics in the US as well as in the U.K. and Switzerland (Richert 
2019, 92-93). The FDA has granted the “breakthrough therapy” designation to MDMA, 
which is currently in Phase 3 efficacy trials as a treatment for Post-Traumatic Stress 
Disorder (PTSD) (MAPS n.d.). Oregon recently became the first state to legalize 
psilocybin for medical use and to decriminalize possessing small amounts of all drugs, 
psychedelics included (Acker 2020). Additionally, several US cities have 
decriminalized psychedelics in recent years, and the California legislature is currently 
considering a bill to decriminalize them statewide (Lozano 2021).  
These developments ought to be welcomed. If the new research into 




use, that could lead to quality-of-life improvements for millions suffering from 
addiction and other mental health issues. Regardless of one’s position on recreational 
drug use, providing sick patients with effective medicine should be non-controversial. 
For this to happen, it is essential that federal controls on psychedelic drugs be updated 
to reflect the growing consensus that they are medically useful and pose a minimal 
public health threat. Liechti notes in 2017 that, despite the recent expansion of research, 
studying psychedelics remains “extremely costly because of overregulation . . . the 
scheduling of LSD still impedes or prohibits clinical research.” 
Fortunately, there is good reason for optimism. Granted, neo-Puritanism remains 
the dominant philosophy in the American drug discourse (Morone 2003, 474). But, 
although it is too soon to say for sure, the anti-drug moral framework may be losing its 
grip on the American collective psyche. Nadelmann and Lasalle (2017) note that, 
although the US lags behind much of the world in evidence-based, harm reduction drug 
policies, there is a wide base of support pushing lawmakers in that direction. The 
growing wave of cannabis legalization across the nation is an especially encouraging 
sign, suggesting that voters are becoming less unequivocally supportive of 
criminalization, and recognizing the harms inflicted by the War on Drugs. 
Polling bears this out; in 2014, a Pew Research Center survey determined that 
two thirds of Americans would prefer for drug policy to shift away from criminalization 
and toward a more public health-oriented approach. I theorize in a previous paper that 
this is in part due to the heavy toll the ongoing opioid epidemic has inflicted on white, 
upper-middle class America. “Firsthand experience may be changing the dominant 




addicts to be imprisoned rather than treated if the addict in question is your child, 
spouse, or close friend” (Sproul 2019, 20-21).  
Although cultural norms and stereotypes are slow to change, the US may have 
finally reached a tipping point, and not a moment too soon. Even ignoring the medical 
possibilities, the hasty criminalization of psychedelics has caused decades of harm. On 
the black market, far more dangerous substances are often sold as “LSD,” causing 
entirely preventable overdoses and deaths (DEA 2013; Kohn 2018). Indeed, considering 
the relative safety of psychedelics, criminalization has almost certainly caused more 
deaths than it has prevented. This just one of a long series of ill-advised policy decisions 
driven by the anti-drug moral framework. Fish says it best: “if we want to improve our 
current drug policy, we should base our thinking on observable evidence and logic 
rather than . . . social prejudices” (1998b, 18). The US has spent billions of dollars, 
thrown millions of non-violent offenders behind bars, and left innumerable medical 
advances undiscovered, yet is no closer to solving the drug problem than it was a 
century ago (The Economist 2018; Shultz and Aspe 2016). Many Americans are finally 





Ayahuasca: A psychedelic herbal brew used for centuries by Indigenous Amazonian 
tribes for ritual purposes. Contains DMT (see below) as well as monoamine oxidase 
inhibitors (MAOIs), enabling the DMT to be absorbed orally. The effects of 
ayahuasca are far longer lasting than vaporized DMT, and very intense even relative 
to other hallucinogens. Consequently, recreational use is rare. (Kuhn et al. 2019, 
128-129). 
Bad Trip: Colloquial term for the most common adverse effect of hallucinogen use: 
acute, intensely unpleasant emotions such as fear or despair, generally coupled with 
disturbing thoughts and/or hallucinations. Although distressing, such experiences do 
not generally cause lasting harm, unless the user’s panic causes them to 
inadvertently hurt themselves (Kuhn et al. 2019, 110). Research suggests that bad 
trips are often a result of the user’s expectations and mindset (Bunce 1979). They 
can be mitigated by the reassuring presence of others who are familiar with 
psychedelics (Becker 1967). 
Cannabis (a.k.a marijuana, weed, pot, grass, etc): A plant that, when smoked or eaten, 
produces wide-ranging and unique psychoactive effects—it is among the most 
popular recreational drugs. Although not strictly categorized as a hallucinogen, 
cannabis has hallucinogenic properties, particularly when eaten (Kuhn et al. 2019, 
174-175). 
DMT (a.k.a. spice, businessman’s special, the spirit molecule): N, N-
dimethyltryptamine, a psychedelic drug derived from certain Amazonian plants. In 




but short-lived (less than 30 min) psychedelic experience. DMT can also be 
consumed orally if combined with a MAOI—see “Ayahuasca” (Kuhn et al. 2019, 
125-126, 128-129). 
Drug: Although the term has no single definition, it is here used to specifically refer to 
illicit psychoactive substances, or psychoactive substances used illicitly (e.g. use of 
opiates or amphetamines without a prescription). Non-psychoactive medications 
(e.g. aspirin) and psychoactive chemicals which are generally legal and socially 
accepted (e.g. alcohol, prescribed psychiatric medications) are excluded.  
Ecstasy: Generally refers to MDMA or similar compounds (e.g. MDA) sold in pill form 
(Kuhn et al. 2019, 96-101). Additionally, on the black market, pills sold as “ecstasy” 
often contain dangerous adulterants (e.g. methamphetamine), and often contain no 
genuine MDMA at all (98-99). 
Hallucinogen/Hallucinogenic Drug: A psychoactive drug with the effect of inducing 
hallucinations and altering a user’s perception of reality. This category includes 
classical psychedelic drugs (See “Psychedelic Drug”) as well as a range of other 
substances. These other substances include dissociative anesthetics like PCP and 
ketamine, belladonna alkaloids like those found in Jimsonweed, and atypical 
hallucinogens such as Salvia divinorum (Kuhn et al. 2019, 109). 
LSD (a.k.a. acid, blotter, tabs, Lucy, etc): Lysergic acid diethylamide or LSD-25, an 
extremely potent psychedelic drug discovered in 1938 by Sandoz Laboratories. LSD 
is by far the best-known psychedelic, and the standard by which all others are 




Marijuana: See “Cannabis.” The term “marijuana” emerged into popular English usage 
in the early 20th century, as criminalization advocates attempted to associate 
cannabis use with Mexican immigrants. “Cannabis” is a less problematic alternative 
(Halperin 2018). 
MDMA (a.k.a. Ecstasy, Molly): Methylenedioxymethamphetamine, a unique drug with 
both stimulant and hallucinogenic properties. Although it does act on the serotonin 
system to induce hallucinations, MDMA operates through different neurological 
mechanisms and has a different risk profile than “classical” psychedelics like LSD. 
Therefore, most drug researchers place MDMA and its relatives in a class of their 
own: “entactogens.” MDMA was not used recreationally until about 1980, so it did 
not play a role in most of the events discussed in this thesis (Kuhn et al. 2019, 96-
101). 
Mescaline: The psychedelic compound responsible for the effects of peyote and other 
psychoactive cacti. Has been used by North American tribes for ritual purposes for 
millennia. Legal in some US states for religious use, otherwise subject to the same 
criminal penalties as other psychedelics (Kuhn et al. 2019, 126-127).  
Mushrooms (a.k.a. magic mushrooms, shrooms): Generally, refers to psilocybin 
mushrooms (see “Psilocybin”). May rarely refer to other hallucinogenic mushroom 
varieties, such as Amanita muscaria (Kuhn et al. 2019, 121, 124). 
Peyote: See “Mescaline.” 
Psilocybin: The compound responsible for the effects of psychedelic mushrooms. Was 




was mostly unknown to European-Americans until the 1930s. The second best-
known psychedelic, after its close cousin LSD (Kuhn et al. 2019, 121). 
Psychedelic Drug: A hallucinogenic chemical that produces profound changes in 
perception, cognition, and mood by acting on the serotonin system. Examples 
include LSD, psilocybin, DMT, and mescaline. Distinct from other types of 
hallucinogen that achieve their effects through mechanisms other than the serotonin 
system (See “Hallucinogen”). Whether MDMA should be included is debatable (see 
“MDMA”) (Kuhn et al. 2019, 133).  
Psychoactive Substance: A chemical which, when administered to a human, induces 
noticeable effects on their mental state. Some of these substances are socially 
accepted, legal, and widely used (e.g. alcohol, caffeine, nicotine) whereas others are 
criminalized (See “Drug”). Some psychoactive substances are legal/acceptable for 
medical use, but considered illicit drugs when used recreationally (e.g. opiate 
painkillers, amphetamines).  
Trip: Colloquial term for a psychedelic drug experience—can be used as a noun or verb 






Ablard, Charles. 1975. Use of Human Volunteers in Experimental Research by the 
Department of Defense, Before the Investigations Subcommittee of the House 
Armed Services Committee. 94th Congress (statement of Charles D. Ablard, 
General Counsel for the United States Army). 
https://www.cia.gov/readingroom/docs/CIA-RDP96-00788R001500160012-7.pdf. 
Abramson, Rudy. 1966. “US Plans Intensive Campaign Against LSD.” New York Times, 
April 10, 1966.  
Acker, Lizzy. 2020. “Oregon Becomes First State to Legalize Psychedelic Mushrooms.” 
OregonLive. The Oregonian, November 4, 2020. 
https://www.oregonlive.com/politics/2020/11/oregon-becomes-first-state-to-
legalize-psychedelic-mushrooms.html.  
Ali, Mansur. 2014. “Perspectives on Drug Addiction in Islamic History and Theology.” 
Religions 5 (3): 912–28. https://doi.org/10.3390/rel5030912.  
American Addiction Centers. 2020. “Drug Laws Around the World: Death Penalty for 
Drugs.” DrugAbuse.com. American Addiction Centers. December 31, 2020. 
https://drugabuse.com/blog/the-20-countries-with-the-harshest-drug-laws-in-the-
world/.  
Anastasopoulos, George, and Harry Photiades. 1962. “Effects of LSD-25 on Relatives 
of Schizophrenic Patients.” Journal of Mental Science 108, no. 452: 95–98. 
https://doi.org/10.1192/bjp.108.452.95.  
Andersen, Kristoffer A., Robin Carhart‐Harris, David J. Nutt, and David Erritzoe. 2020. 
“Therapeutic Effects of Classic Serotonergic Psychedelics: A Systematic Review 
of Modern‐Era Clinical Studies.” Acta Psychiatrica Scandinavica 143, no. 2 
(October 30, 2020): 101–18. https://doi.org/10.1111/acps.13249.  
Andreas, Peter, and Ethan Nadelmann. 2006. Policing the Globe: Criminalization and 
Crime Control in International Relations. Oxford: Oxford University Press. 
https://ebookcentral.proquest.com/lib/uoregon/detail.action?docID=430537. 
 
Ansingler, Harry J. 1937. “The Marihuana Tax Act of 1937 - Additional Statement of H. 
J. Anslinger, Commissioner of Narcotics.” Schaffer Library of Drug Policy, April 
27, 1937. http://www.druglibrary.org/schaffer/hemp/taxact/t10a.htm 
Bayer, István. 1989. “Development of the Convention on Psychotropic Substances, 





Becker, Howard S. 1967. “History, Culture and Subjective Experience: An Exploration 
of the Social Bases of Drug-Induced Experiences.” Journal of Health and Social 
Behavior 8, no. 3: 163. https://doi.org/10.2307/2948371.  
Belouin, Sean J., and Jack E. Henningfield. 2018. “Psychedelics: Where We Are Now, 
Why We Got Here, What We Must Do.” Neuropharmacology 142: 7–19. 
https://doi.org/10.1016/j.neuropharm.2018.02.018.  
Bimmerle, George. 1993. “'Truth' Drugs in Interrogation.” CIA.gov. Central 
Intelligence Agency, September 22, 1993. 
https://www.cia.gov/static/a56eb9be08868b6e14c6ff838ae77087/Truth-Drugs-in-
Interrogation.pdf.  
Blacker, K. H., Reese T. Jones, George C. Stone, and Dolf Pfefferbaum. 1968. “Chronic 
Users of LSD: The ‘Acidheads.’” American Journal of Psychiatry 125, no. 3 
(September): 341–51. https://doi.org/10.1176/ajp.125.3.341.  
Blakeslee, Sandra. 1970. “Study of LSD Spurs Suspicions of Drug's Link to Birth 
Defects.” New York Times, May 5, 1970.  
Brecher, Edward M. 1972. “The Consumers Union Report on Licit and Illicit Drugs - 
Nineteenth-Century America - a ‘Dope Fiend's Paradise.’” Consumer Reports 
Magazine. http://www.druglibrary.org/schaffer/Library/studies/cu/cu1.html. 
Brown, Michael E. 1969. “The Condemnation and Persecution of Hippies.” Trans-
Action 6, no. 10 (September): 33–46. https://doi.org/10.1007/bf03180973. 
Bunce, Richard. 1979. “Social and Political Sources of Drug Effects: The Case of Bad 
Trips on Psychedelics.” Journal of Drug Issues 9, no. 2: 213–33. 
https://doi.org/10.1177/002204267900900207.  
Burnett, Mary M. 1969. “Crisis in Narcotics - Are Existing Federal Penalties 
Effective?” William and Mary Law Review 636. 
https://scholarship.law.wm.edu/wmlr/vol10/iss3/8/.  
Carhart-Harris, Robin L, and Guy M Goodwin. 2017. “The Therapeutic Potential of 
Psychedelic Drugs: Past, Present, and Future.” Neuropsychopharmacology 42, no. 
11 (April 26, 2017): 2105–13. https://doi.org/10.1038/npp.2017.84. 
 
Central Intelligence Agency. 1954. Potential New Agent for Unconventional Warfare. 





Cohen, Sidney. 1960. “Lysergic Acid Diethylamide: Side Effects and Complications.” 
The Journal of Nervous and Mental Disease 130, no. 1 (January): 30–40. 
https://doi.org/10.1097/00005053-196001000-00005.  
Cohen, Stanley. 1987. Folk Devils & Moral Panics. Oxford: Basil Blackwell.  
Collier, David. 2011. “Understanding Process Tracing.” PS: Political Science & Politics 
44, no. 4 (October): 823–30. https://doi.org/10.1017/s1049096511001429. 
 
Cornwell, Benjamin, and Annulla Linders. 2002. “The Myth of ‘Moral Panic’: An 
Alternative Account of LSD Prohibition.” Deviant Behavior 23, no. 4: 307–30. 
https://doi.org/10.1080/01639620290086404. 
 
Crick, Emily. “Drugs as an Existential Threat: An Analysis of the International 
Securitization of Drugs.” International Journal of Drug Policy23, no. 5 (2012): 
407–14. https://doi.org/10.1016/j.drugpo.2012.03.004. 
Das, Saibal, Preeti Barnwal, Anand Ramasamy, Sumalya Sen, and Somnath Mondal. 
2016. “Lysergic Acid Diethylamide: a Drug of ‘Use’?” Therapeutic Advances in 
Psychopharmacology 6, no. 3: 214–28. 
https://doi.org/10.1177/2045125316640440.  
DEA. 2013. “Three More Synthetic Drugs Become Illegal For At Least Two Years.” 
Drug Enforcement Administration. US Department of Justice, November 15, 
2013. https://www.dea.gov/press-releases/2013/11/15/three-more-synthetic-drugs-
become-illegal-least-two-years. 
DEA. 2017. “Drugs of Abuse: A DEA Resource Guide.” Drug Enforcement 
Administration. US Department of Justice. 
https://www.dea.gov/sites/default/files/drug_of_abuse.pdf. 
DEA. n.d. “Controlled Substance Schedules.” DEA Diversion Control Division. Drug 
Enforcement Administration. Accessed March 9, 2021. 
https://www.deadiversion.usdoj.gov/schedules/ 
Degenhardt, Louisa et al. 2008. "Toward a Global View of Alcohol, Tobacco, Cannabis, 
and Cocaine Use: Findings from the WHO World Mental Health Surveys." PLoS 
Medicine 5, no. 7 (July): 1053-067. doi:10.1371/journal.pmed.0050141. 







DiPaolo, Miranda. 2018. “LSD and The Hippies: A Focused Analysis of 
Criminalization and Persecution in The Sixties.” The People, Ideas, and Things 
(PIT) Journal , no. 9. http://pitjournal.unc.edu/content/lsd-and-hippies-focused-
analysis-criminalization-and-persecution-sixties. 
Dreyfuss, John. 1967. “Friend Says LSD Victim Felt He Was Devil Stealing Souls.” Los 
Angeles Times, February 1, 1967.  
Drug Policy Alliance. 2017. “LSD Fact Sheet.” Drug Policy Alliance. Drug Policy 
Alliance, January. 
http://www.drugpolicy.org/sites/default/files/LSD_Facts_Sheet.pdf 
Fish, Jefferson M. 1998a. “Introduction to Part I.” Essay. In How to Legalize Drugs, 
edited by Jefferson M Fish, 2–10. Northvale, NJ: Jason Aronson. 
 
Fish, Jefferson M. 1998b. “Methodological Considerations and Drug Prohibition.” 
Essay. In How to Legalize Drugs, edited by Jefferson M Fish, 12–28. Northvale, 
NJ: Jason Aronson. 
Fiski, Edward B. 1967. “Religion: 'LSD and the Search for God'.” New York Times, 
March 5, 1967.  
Frame, Tom. n.d.  “Psychedelic Timeline.” Psychedelic Times, Accessed March 5, 
2021. https://psychedelictimes.com/psychedelic-timeline/.  
Freedman, Alfred M. 1962. “Autistic Schizophrenic Children.” Archives of General 
Psychiatry 6, no. 3: 203. https://doi.org/10.1001/archpsyc.1962.01710210019003.  
Gasser, Peter, Dominique Holstein, Yvonne Michel, Rick Doblin, Berra Yazar-
Klosinski, Torsten Passie, and Rudolf Brenneisen. 2014. “Safety and Efficacy of 
Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated with 
Life-Threatening Diseases.” Journal of Nervous & Mental Disease 202, no. 7: 
513–20. https://doi.org/10.1097/nmd.0000000000000113.  
Goode, Erich, and Nachman Ben-Yehuda. 1994. “Moral Panics: Culture, Politics, and 
Social Construction.” Annual Review of Sociology 20, no. 1 (August): 149–71. 
https://doi.org/10.1146/annurev.so.20.080194.001053. 
 
Goode, Erich, and Nachman Ben-Yehuda. 2009. Moral Panics: The Social Construction 
of Deviance. 2nd ed. Chichester, U.K.: Wiley-Blackwell. https://ebookcentral-
proquest-com.libproxy.uoregon.edu/lib/uoregon/detail.action?docID=480437. 
 
Goode, Erich. 2008. “Moral Panics and Disproportionality: The Case of LSD Use in the 





Gordon, Noah. 1963. “The Hallucinogenic Drug Cult.” The Reporter, August 15, 1963. 
https://bibliography.maps.org/bibliography/default/citation/11330.  
GovTrack n.d. a. “H.R. 2 (89th).” GovTrack.us. Accessed April 22, 2021. 
https://www.govtrack.us/congress/votes/89-1965/h16.  
GovTrack n.d. b. “H.R. 14096 (90th).” GovTrack.us. Accessed April 22, 2021. 
https://www.govtrack.us/congress/bills/90/hr14096.  
GovTrack n.d. c. “H.R. 18583 (91st).” GovTrack.us. Accessed April 15, 2021. 
https://www.govtrack.us/congress/bills/91/hr18583.   
Gray, Kevin Alexander. 1998. “A Call for an Anti-War Movement.” Essay. In How to 
Legalize Drugs, edited by Jefferson M Fish, 165–209. Northvale, NJ: Jason 
Aronson. 
Halperin, Alex. 2018. “Marijuana: Is It Time to Stop Using a Word with Racist Roots?” 
The Guardian. Guardian News and Media, January 29, 2018. 
https://www.theguardian.com/society/2018/jan/29/marijuana-name-cannabis-
racism.  
Hawdon, James E. 2001. “The Role of Presidential Rhetoric in the Creation of a Moral 
Panic: Reagan, Bush, and the War on Drugs.” Deviant Behavior22, no. 5: 419–45. 
https://doi.org/10.1080/01639620152472813. 
Hendricks, Peter S, C Brendan Clark, Matthew W Johnson, Kevin R Fontaine, and 
Karen L Cropsey. 2014. “Hallucinogen Use Predicts Reduced Recidivism among 
Substance-Involved Offenders under Community Corrections Supervision.” 
Journal of Psychopharmacology 28, no. 1 (January): 62–66. 
https://doi.org/10.1177/0269881113513851.  
Hendricks, Peter S, Michael Scott Crawford, Karen L Cropsey, Heith Copes, N Wiles 
Sweat, Zach Walsh, and Gregory Pavela. 2017. “The Relationships of Classic 
Psychedelic Use with Criminal Behavior in the United States Adult Population.” 
Journal of Psychopharmacology 32, no. 1 (October): 37–48. 
https://doi.org/10.1177/0269881117735685.  
Herschinger, Eva. 2015. "The Drug Dispositif: Ambivalent Materiality and the 
Addiction of the Global Drug Prohibition Regime." Security Dialogue 46, no. 2: 
183-201. doi:10.1177/0967010614552544. 
Hill, Gladwin. 1967. “'Turn On, Tune In, and Drop Out': LSD Users Describe Their 




Huber, Bridget. n.d. “What Do We Know about the Risks of Psychedelics?” Michael 
Pollan. Michael Pollan. Accessed March 9, 2021. 
https://michaelpollan.com/psychedelics-risk-today/.  
Hyams, Joe. 1959. “A New Shock Drug Unlocks Troubled Minds.” Los Angeles Times, 
November 8, 1959.  
Johansen, Pål-Ørjan, and Teri Suzanne Krebs. 2015. “Psychedelics Not Linked to 
Mental Health Problems or Suicidal Behavior: A Population Study.” Journal of 
Psychopharmacology 29, no. 3: 270–79. 
https://doi.org/10.1177/0269881114568039.  
Kennedy, Merrit. 2019. “Oakland City Council Effectively Decriminalizes Psychedelic 
Mushrooms.” NPR. NPR, June 5, 2019. 
https://www.npr.org/2019/06/05/730061916/oakland-city-council-effectively-
decriminalizes-psychedelic-mushrooms. 
Kernbach, Serge. 2013. “Unconventional Research in USSR and Russia: Short 
Overview.” arXiv.org. Cornell University, December 5, 2013. 
https://arxiv.org/abs/1312.1148.  
Kerr, Peter. 1986. “Anatomy of the Drug Issue: How, After Years, It Erupted.” New 
York Times, November 17, 1986. 
https://www.nytimes.com/1986/11/17/us/anatomy-of-the-drug-issue-how-after-
years-it-erupted.html.  
Khatchadourian, Raffi. 2012. “High Anxiety: LSD in the Cold War.” The New Yorker, 
December 15, 2012. https://www.newyorker.com/news/news-desk/high-anxiety-
lsd-in-the-cold-war.  
Kohn, Isabelle. 2018. “Learning How to Tell If Your LSD Is Real or Fake Could Save 
Your Life.” Rooster Magazine, October 20, 2018. 
https://therooster.com/blog/learning-how-tell-if-your-lsd-real-or-fake-could-save-
your-life. 
Kuhn, Cynthia, Scott Swartzwelder, and Wilkie Wilson. 2019. BUZZED: The Straight 
Facts About the Most Used and Abused Drugs from Alcohol to Ecstasy. 5th ed. 
New York, NY: W W Norton. 
Laurence, William L. 1963. “On Hallucinogens - Warning Issued Over the Dangers of 
Improper Use of LSD-25.” New York Times, June 9, 1963.  
Lee, Martin A., and Bruce Shlain. 1985. Acid Dreams: The CIA, LSD, and the Sixties 




Levine, Harry G. “Temperance Cultures.” 1993. Essay. In The Nature of Alcohol and 
Drug-Related Problems, edited by Malcom Lader, Griffith Edwards, and D Colin 







Levine, Harry G., Craig Reinarman. 1998. “The Transition from Prohibition to 
Regulation: Lessons from Alcohol Policy for Drug Policy.” Essay. In How to 
Legalize Drugs, edited by Jefferson M Fish, 259–292. Northvale, NJ: Jason 
Aronson. 
 
Liechti, Matthias E. 2017. “Modern Clinical Research on LSD.” 
Neuropsychopharmacology 42, no. 11 (April): 2114–27. 
https://doi.org/10.1038/npp.2017.86. 
Life. 1966. “LSD - The Exploding Threat of the Mind Drug That Got Out of Control.” 
Life. March 25, 1966. https://www.trippingly.net/lsd-studies/life-magazine-march-
25-1966.  
Lozano, Alicia Victoria. 2021. “New California Bill Would Decriminalize Psychedelics, 
Expunge Criminal Records.” NBCNews.com. NBCUniversal News Group, 
February 18, 2021. https://www.nbcnews.com/news/us-news/new-california-bill-
would-decriminalize-psychedelics-expunge-criminal-records-n1258261.  
MAPS. n.d. “MDMA-Assisted Therapy Study Protocols.” MAPS. Multidisciplinary 
Association for Psychedelic Studies. Accessed March 9, 2021. 
https://maps.org/research/mdma.  
Martin, A. Joyce. 1957. “L.S.D. (Lysergic Acid Diethylamide) Treatment of Chronic 
Psychoneurotic Patients Under Day-Hospital Conditions.” International Journal 
of Social Psychiatry 3, no. 3: 188–95. 
https://doi.org/10.1177/002076405700300304.  
Massing, Michael. 1998. The Fix. New York, NY: Simon et Schuster.  
McNeill, Don. 1966. “Leary - Kennedy Clash on LSD.” East Village Other. June 15, 





Meyer, Roger E. 1967. “Adverse Reactions to Hallucinogenic Drugs – with Background 
Papers.” Proceedings of the Conference Held at the National Institute of Mental 
Health, Chevy Chase, MD, September 29, 1967. 
https://files.eric.ed.gov/fulltext/ED034696.pdf. 
Miles, Barry. 2005. Hippie. New York, NY: Sterling.  
Mogar, Robert E. 1965. “Current Status and Future Trends in Psychedelic (LSD) 
Research.” Journal of Humanistic Psychology 5, no. 2 (October): 147–66. 
https://doi.org/10.1177/002216786500500204.  
Mogar, Robert E., and Charles Savage. 1964. “Personality Change Associated with 
Psychedelic (LSD) Therapy: A Preliminary Report.” Psychotherapy: Theory, 
Research & Practice 1, no. 4: 154–62. https://doi.org/10.1037/h0088594.  
Morgan, Howard Wayne. 1981. Drugs in America. Syracuse, NY: Syracuse University 
Press. 
Morone, James A. 2003. Hellfire Nation: The Politics of Sin in American History. New 
Haven, CT: Yale University Press.  
Nadelmann, Ethan, and Lindsay Lasalle. 2017. "Two Steps Forward, One Step Back: 
Current Harm Reduction Policy and Politics in the United States." Harm 
Reduction Journal 14, no. 1 (June): 37. doi:10.1186/s12954-017-0157-y. 
National Institutes of Health. 1966. “Excerpts from Hearings of the Subcommittee on 
the Executive Reorganization of the Senate Committee on Government Operations 
[Concerning Federal Research and Regulation of LSD].” Medicine on Screen. 
National Institutes of Health, May 24, 1966. 
https://medicineonscreen.nlm.nih.gov/transcripts-lsd-insight-or-insanity/. 
New York Times. 1963. “Damage to Mind from LSD Feared.” New York Times, 
September 13, 1963.  
New York Times. 1966. “A Slaying Suspect Tells of LSD Spree.” New York Times, 
April 12, 1966. 
New York Times. 1968. “Penalties for Possession of LSD Reluctantly Backed by 
Goddard.” New York Times, February 27, 1968.  
New York Times. 1971. “LSD Linked to Dead Youth.” New York Times, January 1, 
1971.  
Nichols, David E., and Charles S. Grob. 2018. “Is LSD Toxic?” Forensic Science 




Nixon, Richard. 1971. “President Nixon on Nation's Drug Problem.” White House Press 
Conference. Speech, June 17, 1971. 
https://www.nixonfoundation.org/2016/06/26404/. 
Nutt, David J, Leslie A King, and Lawrence D Phillips. 2010. “Drug Harms in the UK: 
a Multicriteria Decision Analysis.” The Lancet 376, no. 9752: 1558–65. 
https://doi.org/10.1016/s0140-6736(10)61462-6.  
Nutt, David. 2015. “Illegal Drugs Laws: Clearing a 50-Year-Old Obstacle to Research.” 
PLOS Biology 13, no. 1. https://doi.org/10.1371/journal.pbio.1002047.  
O’Manique, Sophie. 2014. "From Prohibition to Decriminalization: Interrogating the 
Emerging International Paradigm Shift in the War on Drugs Discourse." Master's 
thesis, Carleton University. https://doi.org/10.22215/etd/2014-10336. 
OHCR. 1984. “Convention against Torture.” OHCHR. Office of the United Nations 
High Commissioner for Human Rights, December 10, 1984. 
https://www.ohchr.org/en/ProfessionalInterest/pages/cat.aspx.  
Pahnke, Walter N. 1970. “The Experimental Use of Psychedelic (LSD) Psychotherapy.” 
JAMA: The Journal of the American Medical Association 212, no. 11 (June): 
1856–63. https://doi.org/10.1001/jama.1970.03170240060010.  
Pardo, Bryce, Beau Kilmer, and Wenjing Huang. 2019. “Contemporary Asian Drug 
Policy: Insights and Opportunities for Change.” Research Reports. 
https://doi.org/10.7249/rr2733. 
Pew Research Center. 2014. “America's New Drug Policy Landscape.” The Pew 
Research Center, April 2, 2014. https://www.people-
press.org/2014/04/02/americas-new-drugpolicylandscape/. 
 
Pollan, Michael. 2018. How to Change Your Mind: What the New Science of 
Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and 
Transcendence. NY, NY: Penguin Press. 
Richert, Lucas. 2019. Strange Trips: Science, Culture, and the Regulation of Drugs. 
Montreal: McGill-Queen's University Press.  
Rosborough, Brian Alexander. 1966. “LSD: A Challenge to American Drug Law 
Philosophy.” University of Florida Law Review.  
Schmidt, L A. 1995. “‘A Battle Not Mans but Gods’: Origins of the American 
Temperance Crusade in the Struggle for Religious Authority.” Journal of Studies 




Schumach, Murray. 1996. “Distributor of LSD Recalls All Supplies.” New York Times, 
April 15, 1966.  
Shultz, George P, and Pedro Aspe. 2017. “The Failed War on Drugs.” New York Times. 
New York Times, December 31, 2017. 
https://www.nytimes.com/2017/12/31/opinion/failed-war-on-drugs.html.  
Siff, Stephen. 2015. Acid Hype: American News Media and the Psychedelic Experience. 
Urbana, IL: University of Illinois Press. 
Smith, Jean Paul. 1967. “LSD: The False Illusion.” FDA Papers, 6, 1: 10–18. 
https://bibliography.maps.org/bibliography/default/citation/2042.  
Sproul, Conrad. 2019. “A Cultural Explanation for Illicit Drug Policies in the United 
States and Portugal.” Unpublished manuscript, last modified June 11, 2019. 
Adobe PDF file. https://tinyurl.com/sproul-19. 
Stevens, Jay. 1987. Storming Heaven: LSD and the American Dream. New York, NY: 
Atlantic Monthly Press.  
The Catholic Transcript. 1966. “LSD Cult.” The Catholic Transcript, September 23, 
1966. https://thecatholicnewsarchive.org/?a=d&d=CTR19660923-01.2.32&e=-----
--en-20--1--txt-txIN-------.  
The Economist. 2018. “Stumbling in the Dark.” The Economist. The Economist 
Newspaper. April 14, 2018. https://www.economist.com/special-
report/2018/08/14/stumbling-in-the-dark.  
Thiessen, Michelle S, Zach Walsh, Brian M Bird, and Adele Lafrance. 2018. 
“Psychedelic Use and Intimate Partner Violence: The Role of Emotion 
Regulation.” Journal of Psychopharmacology 32, no. 7: 749–55. 
https://doi.org/10.1177/0269881118771782.  
Torgerson, Dial. 1967. “Patient in Mental Ward - Victim of LSD Starts Long 'Return 
Trip'.” Los Angeles Times, April 27, 1967.  
Torgerson, Dial. 1969. “LSD Killed Daughter, Art Linkletter Says.” Los Angeles Times, 
October 6, 1969.  
Vatz, Richard E., and Lee S. Weinberg. 1998. “Rhetorical Elements of 
Decriminalization.” Essay. In How to Legalize Drugs, edited by Jefferson M Fish, 
61–78. Northvale, NJ: Jason Aronson. 
 
Walsh, J. 1966. “Congress: A New Option for Addicts; a Look at LSD.” Science 152, 




Wasson, R Gordon. 1957. “Seeking the Magic Mushroom.” Life. May 13, 1957. 
http://www.imaginaria.org/wasson/life.htm.  
Winkelman, Michael. 2014. “Psychedelics as Medicines for Substance Abuse 
Rehabilitation: Evaluating Treatments with LSD, Peyote, Ibogaine and 
Ayahuasca.” Current Drug Abuse Reviews 7, no. 2: 101–16. 
https://doi.org/10.2174/1874473708666150107120011. 
Winkler, Franz E. 1960. “Beware of LSD!” Los Angeles Times, May 15, 1960. 
 
 
